@NP	this study	838
@NP	OECs	850
@NP	contused spinal cords of adult rats	878
@NP	contused spinal cords	878
@NP	adult rats	903
@NP	dorsal laminectomy at T10 vertebra	921
@NP	dorsal laminectomy	921
@NP	T10 vertebra	943
@NP	spinal cord	957
@NP	a force of 10 g with NYU II impactor from 25 mmabove	984
@NP	a force	984
@NP	10 g with NYU II impactor from 25 mmabove	995
@NP	10 g	995
@NP	NYU II impactor from 25 mmabove	1005
@NP	NYU II impactor	1005
@NP	25 mmabove	1026
@NP	the exposed cord	1037
@NP	The contused spinal cord	1055
@NP	The	1055
@NP	spinal cord	1068
@NP	injections of OECs in DMEM or DMEM	1089
@NP	injections	1089
@NP	OECs in DMEM or DMEM	1103
@NP	OECs	1103
@NP	DMEM or DMEM	1111
@NP	one week after injury	1133
@NP	one week	1133
@NP	injury	1148
@NP	The migration and distribution of OECs in the contused spinal cord	1156
@NP	The migration and distribution	1156
@NP	OECs in the contused spinal cord	1190
@NP	OECs	1190
@NP	the contused spinal cord	1198
@NP	the	1198
@NP	spinal cord	1211
@NP	the light microscope	1240
@NP	The intact tissue area	1262
@NP	tissue area	1294
@NP	cavity size	1307
@NP	number of myelinated nerve fibers	1320
@NP	number	1320
@NP	myelinated nerve fibers	1330
@NP	neurons labeled by CB-HRP in T8 segment	1358
@NP	neurons	1358
@NP	CB-HRP in T8 segment	1377
@NP	CB-HRP	1377
@NP	T8 segment	1387
@NP	the semi-quantitative techniques at 6 weeks after transplantation	1427
@NP	the semi-quantitative techniques	1427
@NP	6 weeks after transplantation	1463
@NP	6 weeks	1463
@NP	transplantation	1477
@NP	Locomotor ability and conductive function of the spinal cord	1494
@NP	Locomotor ability and conductive function	1494
@NP	the spinal cord	1539
@NP	the BBB score	1573
@NP	cortical somatosensory	1591
@NP	potentials -LRB- CSEP -RRB- recording	1621
@NP	potentials -LRB- CSEP -RRB-	1621
@NP	potentials	1621
@NP	CSEP	1633
@NP	OECs	1650
@NP	both lesion site and tissue	1669
@NP	lesion site	1674
@NP	tissue	1690
@NP	the lesion	1702
@NP	The intact tissue area	1714
@NP	the OECs-transplanted rats	1765
@NP	that in the DMEM-injected animals	1797
@NP	that	1797
@NP	the DMEM-injected animals	1805
@NP	the injured tissue area	1840
@NP	the OECs-rats	1893
@NP	that in the DMEM-rats	1912
@NP	that	1912
@NP	the DMEM-rats	1920
@NP	The number	1935
@NP	myelinated nerve fibers in the lesion site and preserved neurons in T8	1949
@NP	myelinated nerve fibers in the lesion site	1949
@NP	myelinated nerve fibers	1949
@NP	the lesion site	1976
@NP	preserved neurons in T8	1996
@NP	preserved neurons	1996
@NP	T8	2017
@NP	the OECs-group	2049
@NP	the DMEM-group	2072
@NP	the cavity size	2092
@NP	the two groups	2157
@NP	The BBB score and CSEP recording	2173
@NP	a better performance of locomotor ability	2213
@NP	a better performance	2213
@NP	locomotor ability	2237
@NP	conductive function in the OECs-transplanted rats	2259
@NP	conductive function	2259
@NP	the OECs-transplanted rats	2282
@NP	the DMEMinjected animals	2317
@NP	These results	2343
@NP	OECs	2371
@NP	secondary tissue degeneration	2391
@NP	spinal cord injury	2427
@NP	they	2456
@NP	the cavity formation	2475
@NP	they	2497
@NP	morphological preservation and functional improvement	2514
@NP	the contused spinal cord	2571
@NP	the	2571
@NP	spinal cord	2584
@NP	Introduction	2601
@NP	the axons in the peripheral nervous system -LRB- PNS -RRB-	2621
@NP	the axons	2621
@NP	the peripheral nervous system -LRB- PNS -RRB-	2634
@NP	the peripheral nervous system	2634
@NP	PNS	2665
@NP	axons confined within the central nervous system -LRB- CNS -RRB-	2671
@NP	axons	2671
@NP	the central nervous system	2693
@NP	CNS	2721
@NP	their targets	2775
@NP	This	2790
@NP	lack of a permissive environment	2821
@NP	lack	2821
@NP	a permissive environment	2829
@NP	active inhibitory molecules that are rich in the CNS but quite a few in the PNS	2858
@NP	active inhibitory molecules	2858
@NP	the CNS but quite a few in the PNS	2903
@NP	the CNS	2903
@NP	quite a few in the PNS	2915
@NP	quite a few	2915
@NP	the PNS	2930
@NP	the adult mammalian olfactory system	2942
@NP	successful axonal growth and regeneration	2989
@NP	successful axonal growth	2989
@NP	regeneration	3018
@NP	large part	3050
@NP	olfactory ensheathing cells -LRB- OECs -RRB-	3065
@NP	olfactory ensheathing cells	3065
@NP	OECs	3094
@NP	a unique population	3101
@NP	glial cells	3124
@NP	antigenic and morphologic characteristics	3147
@NP	astrocytes , Schwann cells , and oligodendrocytes	3192
@NP	astrocytes	3192
@NP	Schwann cells	3204
@NP	oligodendrocytes	3223
@NP	the expression	3244
@NP	an array of neurotrophic factors and extracellular matrix molecules -LSB- 1	3262
@NP	an array of neurotrophic factors	3262
@NP	an array	3262
@NP	neurotrophic factors	3274
@NP	extracellular matrix molecules -LSB- 1	3299
@NP	extracellular matrix molecules	3299
@NP	1	3331
@NP	3 -RSB-	3333
@NP	OECs	3337
@NP	regeneration of sensory and descending axons and recovery of function	3369
@NP	regeneration	3369
@NP	sensory and descending axons and recovery of function	3385
@NP	sensory and descending axons	3385
@NP	sensory	3385
@NP	descending axons	3397
@NP	recovery of function	3418
@NP	recovery	3418
@NP	function	3430
@NP	varying degrees	3442
@NP	the lesion site	3479
@NP	spinal cord injury -LRB- SCI -RRB-	3498
@NP	spinal cord injury	3498
@NP	SCI	3518
@NP	thoracic spinal transection	3531
@NP	fine electrolytic lesion	3560
@NP	hemisection	3586
@NP	moderate contusion in adult rats -LSB- 4	3603
@NP	moderate contusion	3603
@NP	adult rats -LSB- 4	3625
@NP	adult rats	3625
@NP	4	3637
@NP	6 -RSB-	3639
@NP	addition	3646
@NP	OECs	3656
@NP	transplant donor cells for human SCI therapies	3679
@NP	transplant donor cells	3679
@NP	human SCI therapies	3706
@NP	China , Australia , and Portugal	3729
@NP	7	3761
@NP	12 -RSB-	3763
@NP	grafting of OECs in human SCI patients	3777
@NP	grafting	3777
@NP	OECs in human SCI patients	3789
@NP	OECs	3789
@NP	human SCI patients	3797
@NP	the results from these trials	3849
@NP	the results	3849
@NP	these trials	3866
@NP	the potential for spontaneous recovery	3919
@NP	the potential	3919
@NP	spontaneous recovery	3937
@NP	the limited number of trial	3962
@NP	the limited number	3962
@NP	trial	3984
@NP	experiments -LSB- 12 -RSB-	4025
@NP	experiments	4025
@NP	12 -RSB-	4038
@NP	unknown phenotypes	4048
@NP	fate of OECs , perioperative morbidity and lack of functional benefits	4071
@NP	fate	4071
@NP	OECs , perioperative morbidity and lack	4079
@NP	OECs	4079
@NP	perioperative morbidity	4085
@NP	lack	4113
@NP	functional benefits	4121
@NP	very serious shortcomings -LSB- 13 -RSB-	4145
@NP	very serious shortcomings	4145
@NP	13 -RSB-	4172
@NP	The abilities	4177
@NP	regeneration of central axons and functional recovery	4210
@NP	regeneration	4210
@NP	central axons and functional recovery	4226
@NP	central axons	4226
@NP	functional recovery	4244
@NP	spinal cord injuries	4270
@NP	their expression	4311
@NP	nerve growth factor -LRB- NGF -RRB-	4331
@NP	nerve growth factor	4331
@NP	NGF	4352
@NP	brain-derived neurotrophic factor -LRB- BDNF -RRB-	4358
@NP	brain-derived neurotrophic factor	4358
@NP	BDNF	4393
@NP	glial cell line-derived neurotrophic factor -LRB- GDNF -RRB-	4400
@NP	glial cell	4400
@NP	line-derived neurotrophic factor -LRB- GDNF -RRB-	4411
@NP	line-derived neurotrophic factor	4411
@NP	GDNF	4445
@NP	neurotrophin 4/5 -LRB- NT-4 / 5 -RRB-	4456
@NP	neurotrophin 4/5	4456
@NP	NT-4	4474
@NP	14,15 -RSB-	4483
@NP	sensory axons	4509
@NP	NGF , BDNF , and neurotrophin	4541
@NP	NGF	4541
@NP	BDNF	4546
@NP	neurotrophin	4556
@NP	3 -LRB- NT-3 -RRB- -LSB- 12,15 -RSB-	4569
@NP	3	4569
@NP	NT-3	4572
@NP	12,15 -RSB-	4579
@NP	lesioned rubrospinal and corticospinal axons	4592
@NP	lesioned rubrospinal	4592
@NP	corticospinal axons	4617
@NP	BDNF -LSB- 16 -- 18 -RSB-	4655
@NP	BDNF	4655
@NP	16 -- 18	4661
@NP	NT-4	4669
@NP	5	4674
@NP	atrophy of rat rubrospinal neurons	4685
@NP	atrophy	4685
@NP	rat rubrospinal neurons	4696
@NP	axotomy	4726
@NP	rubrospinal regeneration	4747
@NP	19 -RSB-	4773
@NP	GDNF	4778
@NP	survival and axonal regeneration	4792
@NP	noradrenergic neurons of the locus coeruleus -LSB- 20,21 -RSB-	4828
@NP	noradrenergic neurons	4828
@NP	the locus coeruleus -LSB- 20,21 -RSB-	4853
@NP	the locus coeruleus	4853
@NP	20,21 -RSB-	4874
@NP	OECs	4891
@NP	IL1 , laminin , N-CAM , PSANCAM , and fibronectin	4904
@NP	neurite extension -LSB- 1 -RSB-	4972
@NP	neurite extension	4972
@NP	1 -RSB-	4991
@NP	Contusive injury of spinal cord	4995
@NP	Contusive injury	4995
@NP	spinal cord	5015
@NP	a common type	5030
@NP	damage	5047
@NP	humans	5057
@NP	22,23 -RSB-	5065
@NP	many damaging tissue processes	5082
@NP	the release of excessive excitatory amino acids , Ca +	5138
@NP	the release	5138
@NP	excessive excitatory amino acids , Ca +	5153
@NP	excessive excitatory amino acids	5153
@NP	Ca +	5187
@NP	Ca	5187
@NP	+	5189
@NP	oxygen free-radical that lead to secondary tissue loss	5196
@NP	oxygen free-radical	5196
@NP	lead	5221
@NP	secondary tissue loss	5229
@NP	24 -RSB-	5252
@NP	addition to these changes	5260
@NP	addition	5260
@NP	these changes	5272
@NP	substances inhibitory to axon regeneration	5287
@NP	substances	5287
@NP	regeneration	5317
@NP	a barrier	5340
@NP	growth	5358
@NP	sustenance for surviving nerve cells	5366
@NP	sustenance	5366
@NP	surviving nerve cells	5381
@NP	cavities	5422
@NP	25 -RSB-	5437
@NP	it	5448
@NP	the spread of secondary tissue loss	5472
@NP	the spread	5472
@NP	secondary tissue loss	5486
@NP	formation of the scar and cavity	5516
@NP	formation	5516
@NP	the scar and cavity	5529
@NP	nerve fiber growth across the area of injury	5562
@NP	nerve fiber growth	5562
@NP	the area of injury	5588
@NP	the area	5588
@NP	injury	5600
@NP	the contused spinal cord of rats	5614
@NP	the	5614
@NP	spinal cord of rats	5627
@NP	spinal cord	5627
@NP	rats	5642
@NP	a model	5659
@NP	the effects	5692
@NP	green fluorescence protein	5707
@NP	GFP	5735
@NP	OECs acutely isolated	5752
@NP	OECs	5752
@NP	olfactory bulb of rats on the anatomical structure	5779
@NP	olfactory bulb	5779
@NP	rats on the anatomical structure	5797
@NP	rats	5797
@NP	the anatomical structure	5805
@NP	functional recovery of the contused cord	5834
@NP	functional recovery	5834
@NP	the contused cord	5857
@NP	the	5857
@NP	cord	5870
@NP	It	5876
@NP	OECs	5908
@NP	the intact tissue	5923
@NP	locomotor function	5954
@NP	the formation of cavity	5995
@NP	the formation	5995
@NP	cavity	6012
@NP	the contused spinal cord	6026
@NP	the	6026
@NP	spinal cord	6039
@NP	These results	6052
@NP	human SCI therapy	6089
@NP	the future	6110
@NP	Materials and methods 2.1 .	6126
@NP	Materials and methods 2.1	6126
@NP	Materials	6126
@NP	methods 2.1	6140
@NP	Preparation of OECs from GFP rats OECs	6153
@NP	Preparation	6153
@NP	OECs from GFP rats OECs	6168
@NP	OECs	6168
@NP	GFP rats OECs	6178
@NP	the nerve fiber layer	6211
@NP	the olfactory bulb	6236
@NP	adult GFP rats as previously described -LRB- Sasaki et al. , 2004 . -RRB-	6258
@NP	adult GFP rats	6258
@NP	Sasaki et al. , 2004	6298
@NP	Sasaki	6298
@NP	et al.	6305
@NP	2004	6313
@NP	.	6319
@NP	the caudal 2/3 of the olfactory bulbs	6330
@NP	the caudal 2/3	6330
@NP	the olfactory bulbs	6348
@NP	meninges and white matter	6390
@NP	meninges	6390
@NP	white matter	6403
@NP	scalpel blades	6429
@NP	25 min	6462
@NP	collagenase A -LRB- 0.75 mg/ml , Roche , Basel , Basel-Stadt , Swiss -RRB-	6472
@NP	collagenase A	6472
@NP	0.75 mg/ml	6487
@NP	Roche , Basel	6499
@NP	Basel-Stadt , Swiss	6513
@NP	collagenase D -LRB- 0.75 mg/ml , Roche , Basel , Basel-Stadt , Swiss -RRB-	6534
@NP	collagenase D	6534
@NP	0.75 mg/ml	6549
@NP	Roche , Basel	6561
@NP	Basel-Stadt , Swiss	6575
@NP	papain -LRB- 12 units/ml , Worthinton , Freehold , NJ , USA -RRB-	6599
@NP	papain	6599
@NP	12 units/ml	6607
@NP	Worthinton , Freehold	6620
@NP	NJ , USA	6642
@NP	calciumfree complete saline solution	6654
@NP	trace cysteine at 37 °C on a rotary shaker in a CO2 incubator	6696
@NP	trace cysteine	6696
@NP	37 °C on a rotary shaker in a CO2 incubator	6714
@NP	37 °C	6714
@NP	a rotary shaker in a CO2 incubator	6723
@NP	a rotary shaker	6723
@NP	a CO2 incubator	6742
@NP	Tissue	6759
@NP	very gentle mechanical trituration	6792
@NP	a culture flask for 1 h in DMEM	6849
@NP	a culture flask	6849
@NP	1 h in DMEM	6869
@NP	1 h	6869
@NP	DMEM	6876
@NP	10 % FCS	6886
@NP	nonadherent cells	6922
@NP	Cells	6941
@NP	3 times in DMEM	6959
@NP	3 times	6959
@NP	DMEM	6970
@NP	FCS	6983
@NP	a final concentration of 30,000 cells per micro liter	6990
@NP	a final concentration	6990
@NP	30,000 cells per micro liter	7015
@NP	30,000 cells	7015
@NP	micro liter	7032
@NP	identification	7049
@NP	the isolated cells	7065
@NP	poly-L-lysine coated chamber slide	7110
@NP	DMEM	7161
@NP	10 % FCS and penicillin/streptomycin	7171
@NP	5 -- 7 days	7214
@NP	5	7214
@NP	7 days	7216
@NP	cells	7224
@NP	ice-cold methanol	7246
@NP	primary antibodies rabbit anti-p75	7281
@NP	Chemicon	7317
@NP	Temecula	7327
@NP	CA , USA	7337
@NP	mouse anti S-100	7350
@NP	Chemicon	7368
@NP	Temecula	7378
@NP	CA , USA	7388
@NP	secondary antibodies Alexiflour488 goat anti-mouse -LRB- 1:1000 -RRB-	7417
@NP	secondary antibodies Alexiflour488 goat	7417
@NP	1:1000	7469
@NP	Alexiflour594 goat antirabbit -LRB- 1:1000 -RRB-	7481
@NP	Alexiflour594 goat antirabbit	7481
@NP	1:1000	7512
@NP	Hoechst 33358 -LRB- 1:1000 -RRB-	7544
@NP	Hoechst 33358	7544
@NP	1:1000	7559
@NP	Molecular Probes , Eugene , OR , USA	7576
@NP	Molecular Probes	7576
@NP	Eugene	7594
@NP	OR	7602
@NP	USA	7606
@NP	Antibody staining	7611
@NP	at least 95 % of donor cells	7654
@NP	at least 95 %	7654
@NP	donor cells	7670
@NP	P75 and S-100	7705
@NP	2.2	7720
@NP	Contusion injury Adult	7725
@NP	Sprague Dawley -LRB- SD -RRB- rats -LRB- 200 -- 250 g -RRB-	7753
@NP	Sprague Dawley -LRB- SD -RRB- rats	7753
@NP	SD	7769
@NP	200 -- 250 g	7779
@NP	200	7779
@NP	250 g	7783
@NP	the Third Military Medical University -LRB- TMMU -RRB- guidelines	7815
@NP	TMMU	7854
@NP	surgical procedures and post-op carewere	7876
@NP	surgical procedures	7876
@NP	post-op carewere	7900
@NP	accordance	7930
@NP	protocols approved by TMMU Institutional Animal Care and Use Committee	7946
@NP	protocols	7946
@NP	TMMU Institutional Animal Care and Use Committee	7968
@NP	Rats	8018
@NP	a single intraperitoneal injection	8046
@NP	3 % sodium pentobarbiturate -LRB- 40 -- 50 mg/kg -RRB-	8084
@NP	3 % sodium pentobarbiturate	8084
@NP	40 -- 50 mg/kg	8112
@NP	40	8112
@NP	50 mg/kg	8115
@NP	a sterile laminectomy	8130
@NP	vertebral levels T10	8169
@NP	the dura	8209
@NP	The spinal cords	8219
@NP	an NYU-II impactor	8256
@NP	a dropping weight -LRB- 10.0 g -RRB-	8280
@NP	a dropping weight	8280
@NP	10.0 g	8299
@NP	25 mm above the exposed cord -LSB- 26 -RSB-	8312
@NP	25 mm	8312
@NP	the exposed cord -LSB- 26 -RSB-	8323
@NP	the exposed cord	8323
@NP	26 -RSB-	8341
@NP	injury	8352
@NP	the muscles and skin	8359
@NP	layers	8395
@NP	The procedure	8403
@NP	hind limb paralysis	8429
@NP	all animals	8452
@NP	wound and bladder infections	8476
@NP	Bicillin -LRB- 60000 U/kg , i.m. -RRB-	8506
@NP	Bicillin	8506
@NP	60000 U/kg , i.m.	8516
@NP	60000 U/kg	8516
@NP	i.m.	8528
@NP	7 days and bladder expression	8554
@NP	7 days	8554
@NP	bladder expression	8565
@NP	7 days	8614
@NP	contusion	8627
@NP	2.3	8638
@NP	OECs transplantation Seven days after the initial surgery , the spinal cordswere	8643
@NP	OECs transplantation	8643
@NP	Seven days	8664
@NP	the initial surgery , the spinal cordswere	8681
@NP	the initial surgery	8681
@NP	the spinal cordswere	8702
@NP	anesthesia	8740
@NP	the same site	8754
@NP	1 μl	8769
@NP	30,000 cells	8775
@NP	suspension	8789
@NP	the midline	8819
@NP	the	8834
@NP	cord at a depth of 0.8 mm	8847
@NP	cord	8847
@NP	a depth of 0.8 mm	8855
@NP	a depth	8855
@NP	0.8 mm	8866
@NP	the epicenter of the lesion and 1 mm rostral and caudal	8876
@NP	the epicenter of the lesion	8876
@NP	the epicenter	8876
@NP	the lesion	8893
@NP	1 mm rostral and caudal	8908
@NP	1 mm rostral	8908
@NP	caudal	8925
@NP	the epicenter for a total of 3 μl of cell suspension -LRB- 90,000 cells -RRB-	8935
@NP	the epicenter	8935
@NP	a total of 3 μl of cell suspension -LRB- 90,000 cells -RRB-	8953
@NP	a total	8953
@NP	3 μl of cell suspension -LRB- 90,000 cells -RRB-	8964
@NP	3 μl	8964
@NP	cell suspension -LRB- 90,000 cells -RRB-	8972
@NP	cell suspension	8972
@NP	90,000 cells	8989
@NP	The cell injections	9005
@NP	a drawn glass micropipette	9046
@NP	the pipette	9078
@NP	place for 5 min	9102
@NP	place	9102
@NP	5 min	9112
@NP	each injection	9124
@NP	Control animals	9140
@NP	equal volumes of DMEM	9165
@NP	equal volumes	9165
@NP	DMEM	9182
@NP	the same sites	9196
@NP	the injection	9218
@NP	the muscle and skin	9233
@NP	interrupted sutures	9270
@NP	Rats -LRB- n = 5 at each time point -RRB-	9291
@NP	Rats	9291
@NP	n = 5 at each time point	9297
@NP	n = 5	9297
@NP	n	9297
@NP	5	9299
@NP	each time point	9304
@NP	weeks 1 -- 5	9339
@NP	weeks	9339
@NP	1 -- 5	9345
@NP	n = 10	9354
@NP	n	9354
@NP	= 10	9355
@NP	week 6	9364
@NP	2.4	9372
@NP	Histological procedures and quantification	9377
@NP	1 , 2 , 3 , 4 , 5 , and 6 weeks after transplantation	9423
@NP	1	9423
@NP	2	9426
@NP	3	9429
@NP	4	9432
@NP	5	9435
@NP	6 weeks after transplantation	9442
@NP	6 weeks	9442
@NP	transplantation	9456
@NP	the rats	9472
@NP	physiological saline	9515
@NP	4 % paraformaldehyde for frozen sectioning	9549
@NP	4 % paraformaldehyde	9549
@NP	frozen sectioning	9573
@NP	2 % paraformaldehyde and 2 % glutaraldehyde	9594
@NP	2 % paraformaldehyde	9594
@NP	2 % glutaraldehyde	9618
@NP	PBS -LRB- pH 7.4 -RRB- for plastic embedding and sectioning	9639
@NP	PBS -LRB- pH 7.4 -RRB-	9639
@NP	PBS	9639
@NP	pH 7.4	9644
@NP	plastic embedding and sectioning	9656
@NP	spinal cords	9703
@NP	4 % paraformaldehyde for frozen sections	9747
@NP	4 % paraformaldehyde	9747
@NP	frozen sections	9771
@NP	3 % glutaraldehyde for plastic sections	9790
@NP	3 % glutaraldehyde	9790
@NP	plastic sections	9812
@NP	Frozen longitudinal serial sections of complete cords	9830
@NP	Frozen longitudinal serial sections	9830
@NP	complete cords	9869
@NP	a thickness of 15 μm on a LEICA Cryostat	9896
@NP	a thickness	9896
@NP	15 μm on a LEICA Cryostat	9911
@NP	15 μm	9911
@NP	a LEICA Cryostat	9920
@NP	a heating plate	9947
@NP	Aqua Poly/Mount -LRB- Polysciences , Inc. , Warrington , FL , USA -RRB-	9980
@NP	Aqua Poly/Mount	9980
@NP	Polysciences , Inc. , Warrington , FL , USA	9997
@NP	Polysciences	9997
@NP	Inc.	10011
@NP	Warrington	10017
@NP	FL	10029
@NP	USA	10033
@NP	The sections	10039
@NP	Olympus fluorescence microscope	10072
@NP	DP71 digital camera and software	10126
@NP	DP71 digital camera	10126
@NP	software	10150
@NP	All lesions	10160
@NP	both FITC and Rhodamine excitation wavelengths	10189
@NP	FITC	10194
@NP	Rhodamine excitation wavelengths	10203
@NP	OECs -LRB- which fluoresce only in the green wavelength -RRB-	10259
@NP	OECs	10259
@NP	the green wavelength	10289
@NP	macrophages that autoflouresce in all wavelengths	10315
@NP	macrophages	10315
@NP	all wavelengths	10349
@NP	The digital images	10366
@NP	10 × or 20 ×	10403
@NP	10 ×	10403
@NP	20 ×	10410
@NP	Coronal semi-thin plastic sections -LRB- 1 μm -RRB-	10415
@NP	Coronal semi-thin plastic sections	10415
@NP	1 μm	10451
@NP	tissue block osmicated , dehydrated and embedded for standard plastic embedding	10477
@NP	tissue block	10477
@NP	standard plastic embedding	10529
@NP	Sections	10557
@NP	methylene blue / Azure II	10584
@NP	methylene blue	10584
@NP	Azure II	10600
@NP	Olympus BX50 microscope	10628
@NP	The number of the myelinated nerve fibers in the lesion site	10653
@NP	The number	10653
@NP	the myelinated nerve fibers in the lesion site	10667
@NP	the myelinated nerve fibers	10667
@NP	the lesion site	10698
@NP	5 digital photographs	10729
@NP	different serial coronal sections	10762
@NP	40 × microscope -LRB- 0.029 mm2 -RRB-	10802
@NP	40 × microscope	10802
@NP	0.029 mm2	10818
@NP	animal	10833
@NP	The areas of intact and injured tissues including cavities	10841
@NP	The areas	10841
@NP	intact and injured tissues including cavities	10854
@NP	intact and injured tissues	10854
@NP	cavities	10891
@NP	5 serial coronal sections	10917
@NP	a section-to-section interval of 100 μm using Spot 345 software	10948
@NP	a section-to-section interval	10948
@NP	100 μm using Spot 345 software	10981
@NP	100 μm	10981
@NP	Spot 345 software	10994
@NP	These 5 measurements	11013
@NP	the relative quantification data	11069
@NP	each animal	11106
@NP	2.5	11119
@NP	Retrograde labeling of the spinal neurons	11124
@NP	Retrograde labeling	11124
@NP	the spinal neurons	11147
@NP	6 weeks	11169
@NP	transplantation	11183
@NP	the rats	11200
@NP	pentobarbital sodium and a sterile laminectomy	11232
@NP	pentobarbital sodium	11232
@NP	a sterile laminectomy	11257
@NP	vertebral levels L3	11296
@NP	the dura	11335
@NP	a stereotaxic apparatus	11358
@NP	2 μl choleragenoid B	11383
@NP	subunit-conjugated horseradish peroxidase	11404
@NP	CB-HRP	11447
@NP	List Biological Laboratories , Inc. , CA , USA ; 0.1 % in distilled water	11455
@NP	List Biological Laboratories , Inc. , CA , USA	11455
@NP	List	11455
@NP	Biological Laboratories , Inc. , CA , USA	11460
@NP	0.1 % in distilled water	11500
@NP	0.1 %	11500
@NP	distilled water	11508
@NP	this level	11541
@NP	a glass electrode using	11557
@NP	a glass electrode	11557
@NP	1.0 mmlateral to the midline and 1.0 mm	11593
@NP	1.0 mmlateral	11593
@NP	the midline and 1.0 mm	11610
@NP	the midline	11610
@NP	1.0 mm	11626
@NP	the surface of the dura	11644
@NP	the surface	11644
@NP	the dura	11659
@NP	The solution	11669
@NP	1 min	11700
@NP	the needle	11710
@NP	a further 1 min	11738
@NP	the muscle and skin layers	11779
@NP	Two to three days	11820
@NP	the rats	11845
@NP	an overdose of pentobarbital sodium	11877
@NP	an overdose	11877
@NP	pentobarbital sodium	11892
@NP	200 ml	11951
@NP	20 % sucrose	11961
@NP	PBS -LRB- pH 7.4 -RRB- , followed by 200 ml of 7 % paraformaldehyde in PBS	11976
@NP	PBS -LRB- pH 7.4 -RRB-	11976
@NP	PBS	11976
@NP	pH 7.4	11981
@NP	200 ml of 7 % paraformaldehyde in PBS	12002
@NP	200 ml	12002
@NP	7 % paraformaldehyde in PBS	12012
@NP	7 % paraformaldehyde	12012
@NP	PBS	12035
@NP	pH 7.4	12040
@NP	perfusion	12055
@NP	the spinal cord	12066
@NP	the same fixative for 2 h	12123
@NP	the same fixative	12123
@NP	2 h	12145
@NP	30 % sucrose in PBS	12167
@NP	30 % sucrose	12167
@NP	PBS	12182
@NP	4	12189
@NP	°C overnight	12191
@NP	The specimen including the adjacent areas rostral and caudal to the implant	12205
@NP	The specimen	12205
@NP	the adjacent areas rostral and caudal to the implant	12228
@NP	the adjacent areas rostral	12228
@NP	caudal to the implant	12259
@NP	sodium	12320
@NP	nitroprusside-stabilized tetramethyl benzidine and diaminobenzidine	12327
@NP	Sigma , St Luis , MO , USA	12396
@NP	Sigma	12396
@NP	St Luis	12403
@NP	MO	12412
@NP	USA	12415
@NP	HRP-labeled neurons	12434
@NP	The number of the labeled neurons in T8 segment	12455
@NP	The number	12455
@NP	the labeled neurons in T8 segment	12469
@NP	the labeled neurons	12469
@NP	T8 segment	12492
@NP	5 digital photographs	12518
@NP	different serial sagittal sections under 10 × microscope -LRB- 1.64 mm2 -RRB-	12551
@NP	different serial sagittal sections	12551
@NP	10 × microscope -LRB- 1.64 mm2 -RRB-	12592
@NP	10 × microscope	12592
@NP	1.64 mm2	12608
@NP	2.6	12619
@NP	Behavioral testing	12624
@NP	the BBB locomotor rating scale -LSB- 27	12649
@NP	the BBB locomotor rating scale	12649
@NP	27	12681
@NP	all rats	12686
@NP	locomotor function	12711
@NP	two observers	12733
@NP	the treatment groups	12758
@NP	BBB testing	12780
@NP	1 week post transplantation	12824
@NP	6 weeks post transplantation	12872
@NP	6 weeks	12872
@NP	2.7	12902
@NP	Cortical somatosensory	12907
@NP	potentials	12937
@NP	CSEP	12949
@NP	recording and analysis	12955
@NP	6 weeks	12981
@NP	transplantation	12995
@NP	15 rats -LRB- n = 5 in each group -RRB-	13012
@NP	15 rats	13012
@NP	n = 5 in each group	13021
@NP	n = 5	13021
@NP	n	13021
@NP	5	13023
@NP	each group	13028
@NP	3 % sodium pentobarbiturate	13063
@NP	an injection of atropine sulfate -LRB- 0.8 mg/kg -RRB-	13128
@NP	an injection	13128
@NP	atropine sulfate -LRB- 0.8 mg/kg -RRB-	13144
@NP	atropine sulfate	13144
@NP	0.8 mg/kg	13162
@NP	tracheal secretions	13186
@NP	Both left and right sciatic nerves	13207
@NP	a bipolar platinum wire electrode	13277
@NP	positive current pulses of 10 mA magnitude	13316
@NP	positive current pulses	13316
@NP	10 mA magnitude	13343
@NP	0.25 ms duration	13360
@NP	0.25 ms	13360
@NP	duration	13368
@NP	1 Hz frequency	13382
@NP	CSEP	13398
@NP	record	13407
@NP	a Neuropack -LRB- Nihon Kohden Co , Japan -RRB-	13422
@NP	a Neuropack	13422
@NP	Nihon Kohden Co	13435
@NP	Japan	13452
@NP	a monopolar silver-ball placed on the surface of the sensorimotor cortex	13464
@NP	a monopolar silver-ball	13464
@NP	the surface of the sensorimotor cortex	13498
@NP	the surface	13498
@NP	the sensorimotor cortex	13513
@NP	bregma − 2 mm , lateral 2 mm	13538
@NP	bregma −	13538
@NP	2 mm , lateral 2 mm	13546
@NP	2 mm	13546
@NP	lateral 2 mm	13552
@NP	2	13560
@NP	The effect of electrical stimulation on CSEP	13567
@NP	The effect	13567
@NP	electrical stimulation on CSEP	13581
@NP	electrical stimulation	13581
@NP	CSEP	13607
@NP	terms of latency and amplitude	13628
@NP	terms	13628
@NP	latency and amplitude	13637
@NP	potentials	13684
@NP	all subjects	13698
@NP	the spinal cords	13712
@NP	histological processing	13746
@NP	2.8	13771
@NP	Statistical analysis	13776
@NP	statistical analysis of differences between the groups	13801
@NP	statistical analysis	13801
@NP	differences between the groups	13825
@NP	differences	13825
@NP	the groups	13845
@NP	all quantitative data	13857
@NP	means	13911
@NP	standard error	13917
@NP	Two-tailed student 's t test	13933
@NP	Two-tailed student 's	13933
@NP	the data between groups	13981
@NP	the data	13981
@NP	groups	13998
@NP	One-way ANOVA followed by Dunnett 's post-hoc multiple comparison tests	14006
@NP	One-way ANOVA	14006
@NP	Dunnett 's post-hoc multiple comparison tests	14032
@NP	Dunnett 's	14032
@NP	CSEP	14098
@NP	A probability value of Pb0 .05	14104
@NP	A probability value	14104
@NP	Pb0 .05	14127
@NP	Results Fig. 1 .	14180
@NP	Results	14180
@NP	Fig. 1	14188
@NP	Distribution and migration of OECs	14196
@NP	Distribution and migration	14196
@NP	OECs	14226
@NP	the contused cord over six weeks on the longitudinal frozen sections	14249
@NP	the	14249
@NP	cord	14262
@NP	six weeks on the longitudinal frozen sections	14272
@NP	six weeks	14272
@NP	the longitudinal frozen sections	14285
@NP	the first three weeks after transplantation	14326
@NP	the first three weeks	14326
@NP	transplantation	14354
@NP	OECs	14371
@NP	the lesion site	14396
@NP	some	14417
@NP	them	14425
@NP	the surrounding tissue	14445
@NP	A -- A1 = 1 week ; B -- B1 = 2 weeks ; and C -- C1 = 3 weeks	14469
@NP	A	14469
@NP	A1 = 1 week ; B -- B1 = 2 weeks ; and C -- C1 = 3 weeks	14471
@NP	A1 = 1 week ; B -- B1 = 2 weeks ; and C	14471
@NP	A1 = 1 week	14471
@NP	A1 =	14471
@NP	1 week	14474
@NP	B -- B1 = 2 weeks	14482
@NP	B	14482
@NP	B1 = 2 weeks	14484
@NP	B1	14484
@NP	= 2 weeks	14486
@NP	C	14500
@NP	C1 = 3 weeks	14502
@NP	C1	14502
@NP	= 3 weeks	14504
@NP	4 weeks after transplantation	14518
@NP	4 weeks	14518
@NP	transplantation	14532
@NP	large cavities	14549
@NP	confluence of tissue spaces and cysts	14576
@NP	confluence	14576
@NP	tissue spaces and cysts	14590
@NP	D -- D1	14615
@NP	D	14615
@NP	D1	14619
@NP	OECs	14635
@NP	the wall of the cavity	14654
@NP	the wall	14654
@NP	the cavity	14666
@NP	the cavity -LRB- E -- E1 = 5 weeks ; and F -- F1 = 6 weeks -RRB-	14692
@NP	the cavity	14692
@NP	E -- E1 = 5 weeks ; and F -- F1 = 6 weeks	14704
@NP	E	14704
@NP	E1 = 5 weeks ; and F -- F1 = 6 weeks	14708
@NP	E1 =	14708
@NP	5 weeks ; and F -- F1 = 6 weeks	14711
@NP	5 weeks	14711
@NP	F	14724
@NP	some macrophages	14747
@NP	OECs	14790
@NP	A1	14796
@NP	F1	14799
@NP	enlargements of the frames in A -- F.	14806
@NP	enlargements	14806
@NP	the frames in A -- F.	14822
@NP	the frames	14822
@NP	A -- F.	14836
@NP	F.	14838
@NP	Scale	14841
@NP	100 μm	14851
@NP	A -- F , 220 μm in A1 -- F1	14861
@NP	F , 220 μm in A1	14863
@NP	F	14863
@NP	220 μm in A1	14866
@NP	220 μm	14866
@NP	A1	14876
@NP	Fig. 2 .	14884
@NP	Fig.	14884
@NP	2	14889
@NP	The intact and injured tissues	14892
@NP	the cord on the coronal plastic sections	14926
@NP	the cord	14926
@NP	the coronal plastic sections	14938
@NP	the control -LRB- A1 -- A6 -RRB- group and the OEC group -LRB- B1 -- B6 -RRB-	14970
@NP	the control -LRB- A1 -- A6 -RRB- group	14970
@NP	A1 -- A6	14983
@NP	A1	14983
@NP	A6	14986
@NP	the OEC group -LRB- B1 -- B6 -RRB-	15000
@NP	the OEC group	15000
@NP	B1 -- B6	15015
@NP	B1	15015
@NP	B6	15018
@NP	1	15026
@NP	week	15028
@NP	transplantation	15039
@NP	the injured area	15055
@NP	both groups -LRB- A1 and B1 -RRB-	15087
@NP	both groups	15087
@NP	A1 and B1	15100
@NP	A1	15100
@NP	B1	15107
@NP	enlarged	15115
@NP	the control group -LRB- A2 and A3 -RRB-	15144
@NP	the control group	15144
@NP	A2 and A3	15163
@NP	A2	15163
@NP	A3	15170
@NP	the OEC group -LRB- B2 and B3 -RRB- at 2 and 3 weeks	15182
@NP	the OEC group -LRB- B2 and B3 -RRB-	15182
@NP	the OEC group	15182
@NP	B2 and B3	15197
@NP	B2	15197
@NP	B3	15204
@NP	at 2 and 3 weeks	15208
@NP	the control animals	15229
@NP	most of the cord parenchyma	15249
@NP	most	15249
@NP	the cord parenchyma	15257
@NP	the formation of the large cavity	15299
@NP	the formation	15299
@NP	the large cavity	15316
@NP	4 weeks -LRB- A4 -RRB-	15336
@NP	4 weeks	15336
@NP	A4	15345
@NP	a further decrease of the intact parenchyma	15366
@NP	a further decrease	15366
@NP	the intact parenchyma	15388
@NP	5 weeks -LRB- A5 -RRB-	15413
@NP	A5	15422
@NP	the remaining cord	15433
@NP	the ventral and ventrolateral areas at 6 weeks -LRB- A6 -RRB-	15475
@NP	the ventral and ventrolateral areas	15475
@NP	6 weeks -LRB- A6 -RRB-	15514
@NP	6 weeks	15514
@NP	A6	15523
@NP	the animals	15531
@NP	OECs	15553
@NP	the pathology	15567
@NP	2 to 6 weeks -LRB- B2 -- B6 -RRB-	15608
@NP	2 to 6 weeks	15608
@NP	B2 -- B6	15622
@NP	B2	15622
@NP	B6	15625
@NP	the cords	15631
@NP	much healthier with less damage and denser parenchyma	15646
@NP	much healthier	15646
@NP	less damage and denser parenchyma	15666
@NP	less damage	15666
@NP	denser parenchyma	15682
@NP	Scale	15701
@NP	200 μm	15711
@NP	Fig. 3 .	15720
@NP	Fig.	15720
@NP	3	15725
@NP	The injured area -LRB- A -RRB-	15728
@NP	The injured area	15728
@NP	A	15746
@NP	the intact area -LRB- B -RRB-	15750
@NP	the intact area	15750
@NP	B	15767
@NP	numbers of myelinated nerve fibers	15774
@NP	numbers	15774
@NP	myelinated nerve fibers	15785
@NP	C	15810
@NP	the	15816
@NP	spinal cord receiving DMEM and OEC injections	15829
@NP	spinal cord	15829
@NP	DMEM and OEC injections	15851
@NP	the injured area and the number of myelinated nerve fiber	15885
@NP	the injured area	15885
@NP	the number of myelinated nerve fiber	15906
@NP	the number	15906
@NP	myelinated nerve fiber	15920
@NP	the intact area	15957
@NP	both groups	15986
@NP	six weeks post transplantation	16003
@NP	six weeks	16003
@NP	a statistical difference between the two groups	16034
@NP	a statistical difference	16034
@NP	the two groups	16067
@NP	each time point	16106
@NP	+	16123
@NP	+	16124
@NP	pb0	16127
@NP	.01	16130
@NP	Fig. 4 .	16136
@NP	Fig.	16136
@NP	4	16141
@NP	The coronal plastic sections	16144
@NP	the myelinated nerve fibers	16181
@NP	the spinal cord	16212
@NP	the control group -LRB- A1 -- A6 -RRB- and the OEC group -LRB- B1 -- B6 -RRB-	16231
@NP	the control group	16231
@NP	A1 -- A6	16250
@NP	A1	16250
@NP	A6	16253
@NP	the OEC group	16261
@NP	B1 -- B6	16276
@NP	B1	16276
@NP	B6	16279
@NP	1 week	16287
@NP	a few myelinated nerve fibers	16294
@NP	the injured area -LRB- A1 and B1 -RRB-	16337
@NP	the injured area	16337
@NP	A1 and B1	16355
@NP	A1	16355
@NP	B1	16362
@NP	number	16385
@NP	both groups over following weeks -LRB- A2 -- B6 ; and B2 -- B6 -RRB-	16395
@NP	both groups	16395
@NP	following weeks -LRB- A2 -- B6 ; and B2 -- B6 -RRB-	16412
@NP	following weeks	16412
@NP	A2 -- B6 ; and B2 -- B6	16429
@NP	A2	16429
@NP	B6 ; and B2 -- B6	16432
@NP	B6	16432
@NP	B2	16440
@NP	B6	16443
@NP	the number of myelinated nerve fibers	16452
@NP	the number	16452
@NP	myelinated nerve fibers	16466
@NP	the OEC group	16505
@NP	the control group at each time point	16527
@NP	the control group	16527
@NP	each time point	16548
@NP	Scale	16565
@NP	100 μm	16575
@NP	Fig. 5 .	16584
@NP	Fig.	16584
@NP	5	16589
@NP	The photographic picture -LRB- camera lucida -RRB- of the	16592
@NP	The photographic picture -LRB- camera lucida -RRB-	16592
@NP	The photographic picture	16592
@NP	camera lucida	16618
@NP	the	16637
@NP	cord segment -LRB- A -RRB-	16650
@NP	cord segment	16650
@NP	A	16664
@NP	the injection site -LRB- arrows -RRB-	16675
@NP	the injection site	16675
@NP	arrows	16695
@NP	the cavities -LRB- Ca -RRB-	16704
@NP	the cavities	16704
@NP	Ca	16718
@NP	white -LRB- W -RRB-	16723
@NP	white	16723
@NP	W	16730
@NP	graymatter	16737
@NP	G	16749
@NP	6 weeks after transplantation	16756
@NP	6 weeks	16756
@NP	transplantation	16770
@NP	the longitudinal frozen sections of the cord	16787
@NP	the longitudinal frozen sections	16787
@NP	the cord	16823
@NP	more CB-HRP	16839
@NP	neurons in the OEC group -LRB- C -RRB-	16859
@NP	neurons	16859
@NP	the OEC group -LRB- C -RRB-	16870
@NP	the OEC group	16870
@NP	C	16885
@NP	the DMEM group -LRB- B -RRB-	16896
@NP	the DMEM group	16896
@NP	B	16912
@NP	Scale	16916
@NP	150 μm	16926
@NP	Fig. 6 .	16935
@NP	Fig.	16935
@NP	6	16940
@NP	BBB score	16943
@NP	both DMEM and OEC groups	16956
@NP	DMEM	16961
@NP	OEC groups	16970
@NP	1 week to 6 weeks after transplantation	16986
@NP	1 week	16986
@NP	6 weeks after transplantation	16996
@NP	6 weeks	16996
@NP	transplantation	17010
@NP	all animals	17036
@NP	gradual improvements	17058
@NP	hind limb locomotor function	17082
@NP	the six-week recovery period	17118
@NP	the BBB score of OEC rats	17148
@NP	the BBB score	17148
@NP	OEC rats	17165
@NP	that of DMEM rats	17190
@NP	that	17190
@NP	DMEM rats	17198
@NP	each time point	17211
@NP	+	17228
@NP	+ = pb0 .01 and + = pb0 .05	17229
@NP	= pb0 .01 and	17230
@NP	= pb0	17230
@NP	.01 and	17234
@NP	= pb0 .05	17243
@NP	= pb0	17243
@NP	.05	17247
@NP	Fig. 7 .	17253
@NP	Fig.	17253
@NP	7	17258
@NP	CSEP	17261
@NP	both OECs and DMEM	17287
@NP	OECs	17292
@NP	DMEM	17301
@NP	animals	17315
@NP	the sixth week	17326
@NP	transplantation	17347
@NP	The amplitude	17364
@NP	the latency	17396
@NP	the normal -LRB- A -RRB-	17434
@NP	The difference	17450
@NP	the amplitude -LRB- B -RRB- and the latency -LRB- C -RRB-	17468
@NP	the amplitude	17468
@NP	B	17483
@NP	the latency	17490
@NP	C	17503
@NP	the DMEM group and the OEC group	17514
@NP	the DMEM group	17514
@NP	the OEC group	17533
@NP	* pb0 .01 compared with normal group , and + pb0 .01	17564
@NP	* pb0 .01	17564
@NP	pb0	17565
@NP	.01	17568
@NP	normal group , and + pb0 .01	17586
@NP	normal group	17586
@NP	+ pb0 .01	17604
@NP	+ pb0	17604
@NP	.01	17608
@NP	the DMED and the OEC groups	17629
@NP	the DMED	17629
@NP	the OEC groups	17642
@NP	3.1	17659
@NP	OECs	17664
@NP	1 week	17678
@NP	contusion of the spinal cord	17691
@NP	contusion	17691
@NP	the spinal cord	17704
@NP	the lesion site	17734
@NP	the early stage	17757
@NP	they	17782
@NP	the wall of the cavity	17816
@NP	the wall	17816
@NP	the cavity	17828
@NP	the cavity	17844
@NP	1	17869
@NP	week	17871
@NP	the contusion	17882
@NP	OECs	17897
@NP	the epicenter of the lesion and 1-mm rostral and caudal	17925
@NP	the epicenter	17925
@NP	the lesion and 1-mm rostral and caudal	17942
@NP	the lesion	17942
@NP	1-mm rostral and caudal	17957
@NP	the lesion center	17984
@NP	the first three weeks after transplantation -LRB- Fig. 1A -- C , A1 -- C1 -RRB-	18010
@NP	the first three weeks	18010
@NP	transplantation -LRB- Fig. 1A -- C , A1 -- C1 -RRB-	18038
@NP	transplantation	18038
@NP	Fig. 1A -- C	18055
@NP	Fig. 1A	18055
@NP	C	18063
@NP	A1 -- C1	18066
@NP	A1	18066
@NP	C1	18069
@NP	OECs	18074
@NP	the lesion site	18105
@NP	number of macrophage infiltration and appearance of many tissue spaces and cysts	18126
@NP	number	18126
@NP	macrophage infiltration and appearance	18136
@NP	many tissue spaces and cysts	18178
@NP	Some of the OECs	18208
@NP	Some	18208
@NP	the OECs	18216
@NP	the surrounding tissue for a short distance	18239
@NP	the surrounding tissue	18239
@NP	a short distance	18266
@NP	4 weeks after transplantation	18287
@NP	4 weeks	18287
@NP	transplantation	18301
@NP	large cavities	18318
@NP	confluence of tissue spaces and cysts	18350
@NP	confluence	18350
@NP	tissue spaces and cysts	18364
@NP	the cavities	18396
@NP	OECs and macrophages	18409
@NP	the wall	18450
@NP	the liquid in the cavities -LRB- Fig. 1D , D1 -RRB-	18462
@NP	the liquid	18462
@NP	the cavities -LRB- Fig. 1D , D1 -RRB-	18476
@NP	the cavities	18476
@NP	Fig. 1D , D1	18490
@NP	Fig. 1D	18490
@NP	D1	18499
@NP	there	18515
@NP	a gradual decrease	18525
@NP	number of OECs in both the lesion site and the surrounding tissue	18547
@NP	number of OECs in both the lesion site	18547
@NP	number	18547
@NP	OECs in both the lesion site	18557
@NP	OECs	18557
@NP	both the lesion site	18565
@NP	the surrounding tissue	18590
@NP	the wall of the cavity	18630
@NP	the wall	18630
@NP	the cavity	18642
@NP	the cavity -LRB- Fig. 1E -- F , E1 -- F1 -RRB-	18668
@NP	the cavity	18668
@NP	Fig. 1E -- F	18680
@NP	Fig. 1E	18680
@NP	F	18688
@NP	E1 -- F1	18691
@NP	E1	18691
@NP	F1	18694
@NP	Some of the microphages	18699
@NP	Some	18699
@NP	the microphages	18707
@NP	OECs -LRB- Fig. 1F , F1 -RRB-	18749
@NP	OECs	18749
@NP	Fig. 1F , F1	18755
@NP	Fig. 1F	18755
@NP	F1	18764
@NP	3.2	18769
@NP	OECs	18774
@NP	the intact tissue of the contused spinal cord	18789
@NP	the intact tissue	18789
@NP	the contused spinal cord	18810
@NP	the	18810
@NP	spinal cord	18823
@NP	cavity formation in the spinal cord	18855
@NP	cavity formation	18855
@NP	the spinal cord	18875
@NP	1 week	18894
@NP	transplantation	18907
@NP	the spinal cord	18924
@NP	an injured area	18947
@NP	the dorsal , dorsolateral , and ventrolateral funiculi	18973
@NP	the dorsal	18973
@NP	dorsolateral	18985
@NP	ventrolateral funiculi	19003
@NP	central canal in which lots of macrophages and cysts were found	19032
@NP	central canal	19032
@NP	lots of macrophages and cysts	19055
@NP	lots	19055
@NP	macrophages and cysts	19063
@NP	the injured area	19108
@NP	fusion of the cysts and formation of micro cavities	19153
@NP	fusion	19153
@NP	the cysts and formation of micro cavities	19163
@NP	the cysts and formation	19163
@NP	micro cavities	19190
@NP	4 weeks	19209
@NP	most of the cord parenchyma	19218
@NP	most	19218
@NP	the cord parenchyma	19226
@NP	the formation	19270
@NP	the large cavity resulting in decrease of intact parenchyma of the cord	19287
@NP	the large cavity	19287
@NP	decrease of intact parenchyma of the cord	19317
@NP	decrease	19317
@NP	intact parenchyma of the cord	19329
@NP	intact parenchyma	19329
@NP	the cord	19350
@NP	the remaining cord	19366
@NP	ventral and ventrolateral areas at 6 weeks post transplantation	19408
@NP	ventral and ventrolateral areas	19408
@NP	6 weeks post transplantation	19443
@NP	6 weeks	19443
@NP	the above pathological changes	19482
@NP	both groups	19526
@NP	the cords of the OEC group -LRB- Fig. 2B1 -- B6 -RRB-	19539
@NP	the cords	19539
@NP	the OEC group -LRB- Fig. 2B1 -- B6 -RRB-	19552
@NP	the OEC group	19552
@NP	Fig. 2B1 -- B6	19567
@NP	Fig. 2B1	19567
@NP	B6	19576
@NP	less injured tissue and denser parenchyma	19606
@NP	less injured tissue	19606
@NP	denser parenchyma	19630
@NP	those of the DMEM group -LRB- Fig. 2A1 -- A6 -RRB- from week	19653
@NP	those	19653
@NP	the DMEM group -LRB- Fig. 2A1 -- A6 -RRB- from week	19662
@NP	the DMEM group -LRB- Fig. 2A1 -- A6 -RRB-	19662
@NP	the DMEM group	19662
@NP	Fig. 2A1 -- A6	19678
@NP	Fig. 2A1	19678
@NP	A6	19687
@NP	week	19696
@NP	1 to 6 post transplantation	19701
@NP	Coronal sections through the injured site	19730
@NP	Coronal sections	19730
@NP	the injured site	19755
@NP	the areas of injured and intact tissue and the cavity size	19797
@NP	the areas	19797
@NP	injured and intact tissue and the cavity size	19810
@NP	injured and intact tissue	19810
@NP	the cavity size	19840
@NP	both groups	19860
@NP	the cavities	19873
@NP	the injured sites in different areas	19901
@NP	the injured sites	19901
@NP	different areas	19922
@NP	0.003 mm2	19943
@NP	0.02 mm2	19956
@NP	the first week	19972
@NP	larger cavities	20006
@NP	0.05 mm2 to 0.16 mm2	20027
@NP	0.05 mm2	20027
@NP	0.16 mm2	20039
@NP	the following two weeks	20055
@NP	4 weeks after transplantation	20083
@NP	4 weeks	20083
@NP	transplantation	20097
@NP	the cavity	20113
@NP	maximal area of 0.3 mm2 -LRB- Fig. 2A4 , B4 -RRB-	20132
@NP	maximal area	20132
@NP	0.3 mm2 -LRB- Fig. 2A4 , B4 -RRB-	20148
@NP	0.3 mm2	20148
@NP	Fig. 2A4 , B4	20157
@NP	Fig. 2A4	20157
@NP	B4	20167
@NP	no significant difference between the control and the OEC groups	20176
@NP	no significant difference	20176
@NP	the control and the OEC groups	20210
@NP	the control	20210
@NP	the OEC groups	20226
@NP	the area of injured tissue in animals receiving DMEM	20250
@NP	the area	20250
@NP	injured tissue in animals receiving DMEM	20262
@NP	injured tissue	20262
@NP	animals receiving DMEM	20280
@NP	animals	20280
@NP	DMEM	20298
@NP	1.35 mm2 at 1	20318
@NP	1.35 mm2	20318
@NP	1	20330
@NP	week	20332
@NP	2.02 mm2 at 6 weeks	20340
@NP	2.02 mm2	20340
@NP	6 weeks	20352
@NP	the area of intact tissue	20364
@NP	the area	20364
@NP	intact tissue	20376
@NP	1.47 mm2	20405
@NP	0.8 mm2 over 6 weeks -LRB- Fig. 3A , B -RRB-	20417
@NP	0.8 mm2	20417
@NP	6 weeks -LRB- Fig. 3A , B -RRB-	20430
@NP	6 weeks	20430
@NP	Fig. 3A , B	20439
@NP	Fig. 3A	20439
@NP	B	20448
@NP	the area	20461
@NP	injured tissue in animals receiving OECs increased from 0.41 mm2 to 0.82 mm2	20473
@NP	injured tissue	20473
@NP	animals receiving OECs increased from 0.41 mm2 to 0.82 mm2	20491
@NP	animals	20491
@NP	OECs increased from 0.41 mm2 to 0.82 mm2	20509
@NP	OECs	20509
@NP	0.41 mm2	20529
@NP	0.82 mm2	20541
@NP	decrease of intact area from 2.41 mm2 to 2 mm2	20567
@NP	decrease	20567
@NP	intact area from 2.41 mm2 to 2 mm2	20579
@NP	intact area	20579
@NP	2.41 mm2 to 2 mm2	20596
@NP	2.41 mm2	20596
@NP	2 mm2	20608
@NP	the entire period of six weeks of animal survival	20621
@NP	the entire period	20621
@NP	six weeks of animal survival	20642
@NP	six weeks	20642
@NP	animal survival	20655
@NP	the statistical significance between the two groups	20671
@NP	the statistical significance	20671
@NP	the two groups	20708
@NP	only at 1	20736
@NP	week	20746
@NP	transplantation -LRB- pb0 .01 -RRB-	20757
@NP	transplantation	20757
@NP	pb0 .01	20774
@NP	3.3	20783
@NP	OECs	20788
@NP	the number of myelinated nerve fibers	20803
@NP	the number	20803
@NP	myelinated nerve fibers	20817
@NP	the lesion site	20844
@NP	neurons	20874
@NP	the rostral segment of the spinal cord	20885
@NP	the rostral segment	20885
@NP	the spinal cord	20908
@NP	the animals	20927
@NP	OECs	20949
@NP	a few myelinated nerve fibers	20955
@NP	the injured area	21008
@NP	1 week after transplantation	21028
@NP	1 week	21028
@NP	transplantation	21041
@NP	their number increased during the following weeks -LRB- Fig. 4B1 -- B6 -RRB-	21061
@NP	their number	21061
@NP	the following weeks -LRB- Fig. 4B1 -- B6 -RRB-	21091
@NP	the following weeks	21091
@NP	Fig. 4B1 -- B6	21112
@NP	Fig. 4B1	21112
@NP	B6	21121
@NP	the fibers	21133
@NP	the control animals	21162
@NP	the numbers of myelinated nerve fibers	21183
@NP	the numbers	21183
@NP	myelinated nerve fibers	21198
@NP	that of the animals with OECs at each time point	21238
@NP	that	21238
@NP	the animals with OECs at each time point	21246
@NP	the animals	21246
@NP	OECs at each time point	21263
@NP	OECs	21263
@NP	each time point	21271
@NP	1	21292
@NP	week	21294
@NP	6 weeks -LRB- Fig. 4A1 -- A6 -RRB-	21302
@NP	6 weeks	21302
@NP	Fig. 4A1 -- A6	21311
@NP	Fig. 4A1	21311
@NP	A6	21320
@NP	The semi-quantitative data	21325
@NP	the OEC group	21370
@NP	the average number of myelinated nerve fibers	21384
@NP	the average number	21384
@NP	myelinated nerve fibers	21406
@NP	50.83 ±	21434
@NP	17.14 and 373 ± 77.12	21440
@NP	1 week and 6 weeks	21463
@NP	1 week	21463
@NP	6 weeks	21474
@NP	that	21533
@NP	19.50 ± 6.77 and 192.66 ± 49.76 at 1 week and 6 weeks	21540
@NP	19.50	21540
@NP	± 6.77 and 192.66 ± 49.76	21545
@NP	1 week and 6 weeks	21571
@NP	1 week	21571
@NP	6 weeks	21582
@NP	the control group -LRB- pb0 .01 ; Fig. 3C -RRB-	21607
@NP	the control group	21607
@NP	pb0 .01 ; Fig. 3C	21626
@NP	pb0 .01	21626
@NP	Fig. 3C	21634
@NP	CB-HRP	21644
@NP	neurons	21659
@NP	DMEM and OEC groups	21676
@NP	6 weeks	21716
@NP	transplantation -LRB- Fig. 5 -RRB-	21730
@NP	transplantation	21730
@NP	Fig. 5	21747
@NP	Their number in T8 segment of the cord	21756
@NP	Their number	21756
@NP	T8 segment of the cord	21772
@NP	T8 segment	21772
@NP	the cord	21786
@NP	an area of 1.64 mm2	21810
@NP	an area	21810
@NP	1.64 mm2	21821
@NP	different sections	21835
@NP	The results	21855
@NP	there	21879
@NP	96 ± 15	21890
@NP	neurons	21904
@NP	the OEC group	21915
@NP	more than 65 ± 13 in the DMEM group -LRB- pb0 .01 -RRB-	21954
@NP	more than 65 ± 13	21954
@NP	the DMEM group	21973
@NP	pb0 .01	21989
@NP	3.4	21998
@NP	OECs	22003
@NP	locomotor performance of the transplanted rats	22017
@NP	locomotor performance	22017
@NP	the transplanted rats	22042
@NP	All animals	22064
@NP	gradual improvements	22086
@NP	hind limb locomotor function	22110
@NP	the six-week recovery period	22146
@NP	One week	22176
@NP	transplantation	22191
@NP	BBB scores for OEC transplanted rats	22208
@NP	BBB scores	22208
@NP	OEC transplanted rats	22223
@NP	7.2 ± 1.27	22254
@NP	3.25 ± 1.13 for DMEM injected rats	22276
@NP	3.25	22276
@NP	± 1.13 for DMEM	22280
@NP	± 1.13	22280
@NP	DMEM	22290
@NP	rats	22304
@NP	sixth week after transplantation , OEC	22313
@NP	sixth week	22313
@NP	transplantation , OEC	22330
@NP	transplantation	22330
@NP	OEC	22347
@NP	transplanted rats	22351
@NP	BBB scores of 12.23 ± 1.16	22378
@NP	BBB scores	22378
@NP	12.23 ± 1.16	22392
@NP	10.18 ± 0.96 for DMEM injections	22416
@NP	10.18 ± 0.96	22416
@NP	DMEM injections	22431
@NP	The BBB scores for OEC transplanted rats	22448
@NP	The BBB scores	22448
@NP	OEC transplanted rats	22467
@NP	the controls -LRB- pb0 .01 -RRB- for the first four weeks	22517
@NP	the controls -LRB- pb0 .01 -RRB-	22517
@NP	the controls	22517
@NP	pb0 .01	22531
@NP	the first four weeks	22543
@NP	pb0 .05 for the last two weeks	22568
@NP	pb0 .05	22568
@NP	the last two weeks	22579
@NP	Fig. 6	22599
@NP	3.5	22608
@NP	OECs	22613
@NP	recovery	22627
@NP	CSEP	22639
@NP	the transplanted rats	22647
@NP	the end of the sixth week after transplantation	22672
@NP	the end	22672
@NP	the sixth week after transplantation	22683
@NP	the sixth week	22683
@NP	transplantation	22704
@NP	CSEP	22721
@NP	both OECs and DMEM	22747
@NP	OECs	22752
@NP	DMEM	22761
@NP	animals	22775
@NP	the amplitude	22792
@NP	the latency	22824
@NP	the normal -LRB- Fig. 7A -RRB-	22862
@NP	the normal	22862
@NP	Fig. 7A	22874
@NP	The amplitude of CSEP in normal rats	22884
@NP	The amplitude	22884
@NP	CSEP in normal rats	22901
@NP	CSEP	22901
@NP	normal rats	22909
@NP	1.37 ± 0.16 mV	22925
@NP	1.37 ±	22925
@NP	0.16 mV	22930
@NP	0.42 ± 0.02 mV in the DMEM group and 0.69 ± 0.06 mV	22975
@NP	0.02 mV in the DMEM group	22980
@NP	0.02 mV	22980
@NP	the DMEM group	22991
@NP	0.69 ± 0.06 mV	23010
@NP	0.69 ±	23010
@NP	0.06 mV	23015
@NP	the OEC group	23026
@NP	The comparison between the DMEM group and the OEC group	23041
@NP	The comparison	23041
@NP	the DMEM group and the OEC group	23064
@NP	the DMEM group	23064
@NP	the OEC group	23083
@NP	the significant difference	23115
@NP	Fig. 7B	23153
@NP	Normal Latency of CSEP	23163
@NP	Normal Latency	23163
@NP	CSEP	23181
@NP	6.05 ± 0.32 ms	23190
@NP	6.05 ±	23190
@NP	0.32 ms	23195
@NP	significantly shorter than 13.15 ± 1.22 ms in DMEM animals	23204
@NP	13.15 ± 1.22 ms in DMEM	23231
@NP	13.15 ± 1.22 ms	23231
@NP	DMEM	23248
@NP	10.06 ± 1.04 ms in OECs animals	23265
@NP	10.06 ± 1.04 ms	23265
@NP	OECs animals	23282
@NP	the difference between the DMEM group and the OEC group	23305
@NP	the difference	23305
@NP	the DMEM group and the OEC group	23328
@NP	the DMEM group	23328
@NP	the OEC group	23347
@NP	Fig. 7C	23378
@NP	Discussion	23392
@NP	this study	23406
@NP	GFP-expressing OECs	23418
@NP	contused spinal cord of rats	23461
@NP	contused spinal cord	23461
@NP	rats	23485
@NP	The results	23491
@NP	several novel insights	23510
@NP	OECs	23540
@NP	injured spinal cord	23555
@NP	relations	23584
@NP	the cavity	23599
@NP	macrophage invasion and cavity formation	23619
@NP	the host spinal cord after the contusion	23663
@NP	the host spinal cord	23663
@NP	the contusion	23690
@NP	OECs	23705
@NP	the contused cord	23722
@NP	the	23722
@NP	cord	23735
@NP	the normal cord tissue	23756
@NP	smaller numbers	23787
@NP	short distance	23810
@NP	It	23826
@NP	damaged spinal cord tissue is unfavorable for OECs	23845
@NP	damaged spinal cord tissue	23845
@NP	unfavorable for OECs	23875
@NP	unfavorable	23875
@NP	OECs	23891
@NP	The toxicity of the lesion site to transplanted OECs	23920
@NP	The toxicity	23920
@NP	the lesion site to transplanted OECs	23936
@NP	the lesion site	23936
@NP	transplanted OECs	23955
@NP	differences in the survival rate -LSB- 28 -RSB-	23998
@NP	differences	23998
@NP	the survival rate -LSB- 28 -RSB-	24013
@NP	the survival rate	24013
@NP	28 -RSB-	24032
@NP	That	24037
@NP	the timing of OECs transplantation	24049
@NP	the timing	24049
@NP	OECs transplantation	24063
@NP	7 days	24102
@NP	contusion	24115
@NP	the time of injury	24149
@NP	the time	24149
@NP	injury	24161
@NP	29 -RSB-	24169
@NP	in vitro apoptosis of OECs	24186
@NP	in vitro apoptosis	24186
@NP	OECs	24208
@NP	acutely injured spinal cord explants	24263
@NP	delayed injury explants -LSB- 30 -RSB-	24312
@NP	delayed injury explants	24312
@NP	30 -RSB-	24337
@NP	In vivo OECs transplanted into the injured spinal cord	24342
@NP	In vivo OECs	24342
@NP	the injured spinal cord	24373
@NP	24 h -LSB- 31 -RSB-	24418
@NP	24 h	24418
@NP	31 -RSB-	24424
@NP	Previous studies	24429
@NP	bulb-derived OECs	24465
@NP	the host spinal cord for 2 to 8 months -LSB- 32	24498
@NP	the host spinal cord	24498
@NP	2 to 8 months -LSB- 32	24523
@NP	2 to 8 months	24523
@NP	32	24538
@NP	3 months only 2.3	24553
@NP	± 1.4 % of the OECs	24570
@NP	± 1.4 %	24570
@NP	the OECs	24579
@NP	the number transplanted -LSB- 35 -RSB-	24602
@NP	the number transplanted	24602
@NP	35 -RSB-	24627
@NP	OECs	24641
@NP	the host tissue	24663
@NP	up to 700 μm	24679
@NP	the lesion epicenter at sevendays	24697
@NP	the lesion epicenter	24697
@NP	sevendays	24721
@NP	transplantation -LSB- 36 -RSB-	24737
@NP	transplantation	24737
@NP	36 -RSB-	24754
@NP	It	24759
@NP	OECswere	24785
@NP	lesion site	24808
@NP	most cells	24821
@NP	the injection	24854
@NP	lesion site	24869
@NP	OECs	24891
@NP	2.5-mm outside of the lesion site	24905
@NP	2.5-mm outside	24905
@NP	the lesion site	24923
@NP	the lesion	24951
@NP	OECs	24974
@NP	injury signals	24997
@NP	axonal re-growth	25036
@NP	the lesion -LSB- 37 -RSB-	25075
@NP	the lesion	25075
@NP	37 -RSB-	25087
@NP	It	25092
@NP	survival and migration	25126
@NP	OECs	25150
@NP	the intact tissue	25177
@NP	contused spinal cord , which has been confirmed previously -LSB- 29,38	25198
@NP	contused spinal cord	25198
@NP	29,38	25257
@NP	the same time	25268
@NP	a significant reduction in the injured area	25283
@NP	a significant reduction	25283
@NP	the injured area	25310
@NP	1 week to 6 weeks only	25342
@NP	1 week	25342
@NP	6 weeks only	25352
@NP	OEC transplantation -LRB- Figs. 2 and 3A and B -RRB-	25371
@NP	OEC transplantation	25371
@NP	Figs. 2 and 3A and B	25392
@NP	Figs. 2	25392
@NP	3A and B	25404
@NP	addition	25418
@NP	neurons labeled by CB-HRP in rostral segment to the lesion sites	25428
@NP	neurons	25428
@NP	CB-HRP in rostral segment	25447
@NP	CB-HRP	25447
@NP	rostral segment	25457
@NP	the lesion sites	25476
@NP	number	25511
@NP	OEC transplantation -LRB- Fig. 3C -RRB-	25524
@NP	OEC transplantation	25524
@NP	Fig. 3C	25545
@NP	These data	25555
@NP	the spinal tissue	25586
@NP	particular ventrolateral white matter	25616
@NP	the locomotor capacity of spinal cord injured rats -LSB- 39 -RSB-	25684
@NP	the locomotor capacity	25684
@NP	spinal cord injured rats -LSB- 39 -RSB-	25710
@NP	spinal cord	25710
@NP	rats -LSB- 39 -RSB-	25730
@NP	rats	25730
@NP	39 -RSB-	25736
@NP	these facts with more neurons	25747
@NP	these facts	25747
@NP	more neurons	25764
@NP	it	25787
@NP	OECs	25812
@NP	secondary tissue degeneration	25828
@NP	spinal cord injury	25864
@NP	The mechanism of such a restorative role of OECs	25884
@NP	The mechanism	25884
@NP	such a restorative role of OECs	25901
@NP	such a restorative role	25901
@NP	OECs	25928
@NP	it	25949
@NP	neurotrophic factors such as BDNF , NGF , GDNF , and NT-4	25981
@NP	neurotrophic factors	25981
@NP	BDNF , NGF , GDNF , and NT-4	26010
@NP	BDNF	26010
@NP	NGF	26016
@NP	GDNF	26021
@NP	NT-4	26031
@NP	5 expressed by OECs	26036
@NP	5	26036
@NP	OECs	26051
@NP	14,15	26073
@NP	BDNF	26081
@NP	tissue necrosis	26111
@NP	spinal cord injury -LSB- 40 -RSB-	26133
@NP	spinal cord injury	26133
@NP	40 -RSB-	26153
@NP	sensory axons	26176
@NP	rubrospinal and cortico-spinal axons	26191
@NP	NGF , BDNF , and NT-3 -LSB- 16 -- 18,41,42 -RSB-	26246
@NP	NGF , BDNF , and NT-3	26246
@NP	16 -- 18,41,42	26267
@NP	NT-4	26281
@NP	5	26286
@NP	atrophy of rat rubrospinal neurons	26297
@NP	atrophy	26297
@NP	rat rubrospinal neurons	26308
@NP	axotomy	26338
@NP	rubrospinal regeneration	26359
@NP	19 -RSB-	26385
@NP	Gorrie et al.	26400
@NP	Gorrie	26400
@NP	et al.	26407
@NP	the astrogliosis	26433
@NP	OECs	26453
@NP	transplanted animals	26458
@NP	modulation	26503
@NP	the inflammation	26517
@NP	the spinal cord	26537
@NP	an important process removing cellular debris after injury	26563
@NP	an important process	26563
@NP	cellular debris	26593
@NP	injury	26615
@NP	secondary damage	26656
@NP	the cord	26676
@NP	43 -RSB-	26686
@NP	the present study	26694
@NP	the number of myelinated nerve fibers	26713
@NP	the number	26713
@NP	myelinated nerve fibers	26727
@NP	the OEC group	26775
@NP	the control group over sixweek survival	26797
@NP	the control group	26797
@NP	sixweek survival	26820
@NP	The increase of myelinated nerve fibers in the injured area	26838
@NP	The increase	26838
@NP	myelinated nerve fibers in the injured area	26854
@NP	myelinated nerve fibers	26854
@NP	the injured area	26881
@NP	the re-myelination of the fibers	26912
@NP	the re-myelination	26912
@NP	the fibers	26934
@NP	SCI	26951
@NP	it	26967
@NP	Schwann cells	26996
@NP	OECs	27011
@NP	the nerve fibers	27033
@NP	SCI -LSB- 44 , also review in Ref	27056
@NP	SCI -LSB- 44	27056
@NP	SCI	27056
@NP	44	27061
@NP	review in Ref	27070
@NP	review	27070
@NP	Ref	27080
@NP	45 -RSB- , which is important because remaining deficits after injury	27085
@NP	45 -RSB-	27085
@NP	remaining deficits after injury	27117
@NP	remaining deficits	27117
@NP	injury	27142
@NP	demyelination of spared axons -LSB- 46 -RSB-	27170
@NP	demyelination	27170
@NP	spared axons -LSB- 46 -RSB-	27187
@NP	spared axons	27187
@NP	46 -RSB-	27201
@NP	these anatomical evidences	27215
@NP	functional improvements in the locomotor ability -LSB- 33,47 -RSB-	27268
@NP	functional improvements	27268
@NP	the locomotor ability -LSB- 33,47 -RSB-	27295
@NP	the locomotor ability	27295
@NP	33,47 -RSB-	27318
@NP	it	27326
@NP	the remyelination	27346
@NP	a role in the improvement at the early stage	27372
@NP	a role	27372
@NP	the improvement at the early stage	27382
@NP	the improvement	27382
@NP	the early stage	27401
@NP	OEC transplantation as time needed	27423
@NP	OEC transplantation	27423
@NP	time needed	27446
@NP	time	27446
@NP	We	27459
@NP	early improvement of the spinal cord function	27475
@NP	early improvement	27475
@NP	the spinal cord function	27496
@NP	the neurotrophic factors	27542
@NP	the host tissue evoked by the transplantation and the OECs	27572
@NP	the host tissue	27572
@NP	the transplantation and the OECs	27598
@NP	the transplantation	27598
@NP	the OECs	27622
@NP	the remyelination	27640
@NP	the function of the injured cord	27677
@NP	the function	27677
@NP	the injured cord	27693
@NP	a later stage	27713
@NP	this late effect	27736
@NP	the neurotrophic factors	27772
@NP	the primary causes of human SCI	27801
@NP	the primary causes	27801
@NP	human SCI	27823
@NP	automobile collisions	27837
@NP	violence	27872
@NP	injuries	27893
@NP	events	27914
@NP	SCI patients	27925
@NP	the contusive injury	27938
@NP	the cord	27976
@NP	neural functions	28002
@NP	the level of injury	28029
@NP	the level	28029
@NP	injury	28042
@NP	reference 48 -RSB-	28081
@NP	reference	28081
@NP	contusion	28102
@NP	sequential pathological changes	28113
@NP	hemorrhage	28155
@NP	edema , axonal and neuronal necrosis	28167
@NP	demyelination followed by cavity formation	28208
@NP	demyelination	28208
@NP	cavity formation	28234
@NP	the lesion site	28268
@NP	massive number of macrophages	28304
@NP	massive number	28304
@NP	macrophages	28322
@NP	other polymorphonuclear cells -LSB- 34,49,50 -RSB-	28338
@NP	other polymorphonuclear cells	28338
@NP	34,49,50 -RSB-	28369
@NP	this study	28383
@NP	all these cytopathological changes	28395
@NP	the anatomical structure of the cord	28452
@NP	the anatomical structure	28452
@NP	the cord	28480
@NP	the cavity	28507
@NP	the OEC transplantation	28541
@NP	The result about the cavity	28566
@NP	The result	28566
@NP	the cavity	28583
@NP	that reported by Plant	28612
@NP	that	28612
@NP	Plant	28629
@NP	et al in 2003 -LSB- 29	28636
@NP	et al	28636
@NP	2003 -LSB- 29	28645
@NP	Ramer	28659
@NP	et al in 2004 -LSB- 36 -RSB-	28666
@NP	et al	28666
@NP	2004 -LSB- 36 -RSB-	28675
@NP	2004 -LSB-	28675
@NP	they	28695
@NP	bulb - and mucosa-derived OECs	28713
@NP	the contused T9	28748
@NP	T10 segment and crushed C4 segment of the rat cord	28764
@NP	T10 segment and crushed C4 segment	28764
@NP	the rat cord	28802
@NP	a significant decrease of cavity size.We	28821
@NP	a significant decrease	28821
@NP	cavity size.We	28847
@NP	the differencemay result	28875
@NP	the degree of injury	28910
@NP	the degree	28910
@NP	injury	28924
@NP	the contusion and the crush	28941
@NP	the contusion	28941
@NP	the crush	28959
@NP	the contusion an impact force of 10 g-25 cm was imposed in this study	28991
@NP	the contusion	28991
@NP	an impact force of 10 g-25 cm	29005
@NP	an impact force	29005
@NP	10 g-25 cm	29024
@NP	this study	29050
@NP	that of 10 g-12.5 mm in Plant	29076
@NP	that	29076
@NP	10 g-12.5 mm in Plant	29084
@NP	10 g-12.5 mm	29084
@NP	Plant	29100
@NP	et al in 2003 -LSB- 29 -RSB- , which resulted in 9.9 % and 23 %	29107
@NP	et al	29107
@NP	2003 -LSB- 29 -RSB- , which resulted in 9.9 % and 23 %	29116
@NP	2003	29116
@NP	29 -RSB- , which resulted in 9.9 % and 23 %	29122
@NP	29 -RSB-	29122
@NP	9.9 % and 23 %	29145
@NP	9.9 %	29145
@NP	23 %	29154
@NP	tissue	29165
@NP	26 -RSB-	29186
@NP	the number of transplanted OECs , 120,000 and 150,000 used previously	29201
@NP	the number	29201
@NP	transplanted OECs , 120,000 and 150,000 used previously	29215
@NP	transplanted OECs	29215
@NP	120,000 and 150,000 used previously	29234
@NP	120,000 and 150,000	29234
@NP	90,000 in the current study	29274
@NP	90,000	29274
@NP	the current study	29284
@NP	the difference	29320
@NP	the relation of the cell number and the repair	29346
@NP	the relation	29346
@NP	the cell number and the repair	29362
@NP	the cell number	29362
@NP	the repair	29382
@NP	the future study	29418
@NP	the cavity formation in the contused spinal cord	29445
@NP	the cavity formation	29445
@NP	the contused spinal cord	29469
@NP	the OEC transplantation	29515
@NP	all animals receiving OECs	29540
@NP	all animals	29540
@NP	OECs	29562
@NP	better functional performance	29577
@NP	these of the control animals	29612
@NP	these	29612
@NP	the control animals	29621
@NP	BBB testing	29648
@NP	the first 4 weeks	29679
@NP	OECs transplantation	29703
@NP	Ruitenberg , et al. , 2003 -LSB- 46 -RSB-	29759
@NP	Ruitenberg	29759
@NP	et al.	29771
@NP	2003	29779
@NP	46 -RSB-	29785
@NP	the sixth week CSEP in OECs-injected animals	29805
@NP	the sixth week CSEP	29805
@NP	OECs-injected animals	29828
@NP	their amplitude and latency	29889
@NP	both BBB testing and CSEP recording	29926
@NP	the function of the contused spinal cord	29976
@NP	the function	29976
@NP	the contused spinal cord	29992
@NP	the	29992
@NP	spinal cord	30005
@NP	normal level	30038
@NP	We	30052
@NP	spinal cord function	30077
@NP	the protective potential of OECs on the host tissue	30114
@NP	the protective potential	30114
@NP	OECs on the host tissue	30142
@NP	OECs	30142
@NP	the host tissue	30150
@NP	It	30167
@NP	a fact	30173
@NP	more intact tissue	30192
@NP	more fibers	30212
@NP	more preserved neurons	30225
@NP	smaller lesion size	30252
@NP	the tissue of the injured spinal cord	30273
@NP	the tissue	30273
@NP	the injured spinal cord	30287
@NP	animals receiving OECs transplantation	30333
@NP	animals	30333
@NP	OECs transplantation	30351
@NP	The correlation between the lesion size and the functional performance	30373
@NP	The correlation	30373
@NP	the lesion size and the functional performance	30397
@NP	the lesion size	30397
@NP	the functional performance	30417
@NP	26,38,46 -RSB-	30478
@NP	the lesion size	30505
@NP	impaired hind limb performance	30541
@NP	we	30579
@NP	the OECs-mediated tissue preservation	30595
@NP	the functional recovery	30646
@NP	more to the functional recovery than nerve regeneration and axon remyelination	30692
@NP	the functional recovery than nerve regeneration and axon	30700
@NP	the functional recovery	30700
@NP	nerve regeneration and axon	30729
@NP	early stages	30774
@NP	implantation	30793
@VP	were transplanted into contused spinal cords of adult rats	855
@VP	transplanted into contused spinal cords of adult rats	860
@VP	contused spinal cord	1059
@VP	received injections of OECs in DMEM or DMEM alone at one week after injury	1080
@VP	contused spinal cord	1202
@VP	were observed by the light microscope	1223
@VP	observed by the light microscope	1228
@VP	labeled by CB-HRP in T8 segment	1366
@VP	were evaluated by the BBB score	1555
@VP	evaluated by the BBB score	1560
@VP	evoked potentials -LRB- CSEP -RRB- recording	1614
@VP	were found in both lesion site and tissue near the lesion	1655
@VP	found in both lesion site and tissue near the lesion	1660
@VP	was significantly smaller in the OECs-rats than that in the DMEM-rats	1864
@VP	was significantly greater in the OECs-group than in the DMEM-group	2020
@VP	detected was not significantly different between the two groups	2108
@VP	was not significantly different between the two groups	2117
@VP	can counteract secondary tissue degeneration after spinal cord injury	2376
@VP	counteract secondary tissue degeneration after spinal cord injury	2380
@VP	can not reduce the cavity formation	2461
@VP	reduce the cavity formation	2468
@VP	contused spinal cord	2575
@VP	1	2598
@VP	confined within the central nervous system	2677
@VP	fail to regenerate and re-innervate their targets	2739
@VP	to regenerate and re-innervate their targets	2744
@VP	regenerate and re-innervate their targets	2747
@VP	are rich in the CNS but quite a few in the PNS	2891
@VP	is feasible and relatively safe	3816
@VP	having randomized experiments -LSB- 12 -RSB-	4007
@VP	randomized experiments -LSB- 12 -RSB-	4014
@VP	are very serious shortcomings -LSB- 13 -RSB-	4141
@VP	Injured ascending sensory axons	4491
@VP	ascending sensory axons	4499
@VP	are responsive to NGF , BDNF , and neurotrophin	4523
@VP	are responsive to BDNF -LSB- 16 -- 18 -RSB-	4637
@VP	prevents atrophy of rat rubrospinal neurons after axotomy	4676
@VP	promotes rubrospinal regeneration -LSB- 19 -RSB-	4738
@VP	are involved in neurite extension -LSB- 1 -RSB-	4956
@VP	involved in neurite extension -LSB- 1 -RSB-	4960
@VP	are initiated , including the release of excessive excitatory amino acids , Ca +	5113
@VP	initiated , including the release of excessive excitatory amino acids , Ca +	5117
@VP	-LSB- 24 -RSB-	5251
@VP	to axon regeneration	5309
@VP	axon regeneration	5312
@VP	appear as a barrier to axon growth	5330
@VP	to axon growth	5350
@VP	axon growth	5353
@VP	is diminished	5403
@VP	diminished	5406
@VP	form -LSB- 25 -RSB-	5431
@VP	halt the spread of secondary tissue loss	5467
@VP	reduce formation of the scar and cavity	5509
@VP	promote nerve fiber growth across the area of injury	5554
@VP	contused spinal cord of rats	5618
@VP	grafting	5670
@VP	contused cord	5861
@VP	increased the intact tissue and improved locomotor function	5913
@VP	increased the intact tissue	5913
@VP	improved locomotor function	5945
@VP	failed to reduce the formation of cavity within the contused spinal cord	5978
@VP	to reduce the formation of cavity within the contused spinal cord	5985
@VP	reduce the formation of cavity within the contused spinal cord	5988
@VP	contused spinal cord	6030
@VP	should be valuable for human SCI therapy in the future	6066
@VP	be valuable for human SCI therapy in the future	6073
@VP	2	6123
@VP	described	6287
@VP	dissected free of meninges and white matter	6372
@VP	minced with scalpel blades	6417
@VP	removing and washing nonadherent cells	6901
@VP	washed and plated on poly-L-lysine coated chamber slide	7089
@VP	cultured in DMEM with 10 % FCS and penicillin/streptomycin	7149
@VP	fixed with ice-cold methanol	7235
@VP	showed that at least 95 % of donor cells were both positive for P75 and S-100	7642
@VP	were both positive for P75 and S-100	7682
@VP	approved by TMMU Institutional Animal Care and Use Committee	7956
@VP	was performed at vertebral levels T10 without disrupting the dura	8152
@VP	performed at vertebral levels T10 without disrupting the dura	8156
@VP	disrupting the dura	8198
@VP	were closed in layers	8380
@VP	closed in layers	8385
@VP	resulted in hind limb paralysis in all animals	8417
@VP	To prevent wound and bladder infections	8465
@VP	prevent wound and bladder infections	8468
@VP	was performed twice daily for 7 days after contusion	8584
@VP	performed twice daily for 7 days after contusion	8588
@VP	re-exposed under anesthesia at the same site	8723
@VP	were performed using a drawn glass micropipette	9025
@VP	performed using a drawn glass micropipette	9030
@VP	using a drawn glass micropipette	9040
@VP	remained in place for 5 min after each injection	9090
@VP	received equal volumes of DMEM alone at the same sites	9156
@VP	were closed with interrupted sutures	9253
@VP	closed with interrupted sutures	9258
@VP	were evaluated at weeks 1 -- 5 and -LRB- n = 10 -RRB- at week 6	9321
@VP	evaluated at weeks 1 -- 5 and -LRB- n = 10 -RRB- at week 6	9326
@VP	Transplanted spinal cords were removed	9690
@VP	were removed	9716
@VP	removed	9721
@VP	cut at a thickness of 15 μm on a LEICA Cryostat	9889
@VP	dried on a heating plate	9938
@VP	examined using Olympus fluorescence microscope	10057
@VP	using Olympus fluorescence microscope	10066
@VP	photographed with DP71 digital camera and software	10108
@VP	fluoresce only in the green wavelength	10271
@VP	autoflouresce in all wavelengths	10332
@VP	were collected at 10 × or 20 ×	10385
@VP	collected at 10 × or 20 ×	10390
@VP	osmicated , dehydrated and embedded for standard plastic embedding	10490
@VP	osmicated	10490
@VP	dehydrated	10501
@VP	embedded for standard plastic embedding	10516
@VP	stained with methylene blue / Azure II	10571
@VP	observed under Olympus BX50 microscope	10613
@VP	using Spot 345 software	10988
@VP	were added	11034
@VP	added	11039
@VP	averaged to produce the relative quantification data for each animal	11049
@VP	to produce the relative quantification data for each animal	11058
@VP	produce the relative quantification data for each animal	11061
@VP	performed at vertebral levels L3 without disrupting the dura	11283
@VP	disrupting the dura	11324
@VP	placed in a stereotaxic apparatus	11348
@VP	was injected at this level with a glass electrode using	11525
@VP	injected at this level with a glass electrode using	11529
@VP	using	11575
@VP	was injected over 1 min	11682
@VP	injected over 1 min	11686
@VP	left in situ for a further 1 min before withdrawing	11721
@VP	withdrawing	11761
@VP	were sutured	11806
@VP	sutured	11811
@VP	were anesthetized with an overdose of pentobarbital sodium	11854
@VP	followed by 200 ml of 7 % paraformaldehyde in PBS	11990
@VP	immediately removed	12086
@VP	postfixed in the same fixative for 2 h	12110
@VP	then immersed in 30 % sucrose in PBS at 4	12150
@VP	to the implant	12266
@VP	implant	12273
@VP	to visualize HRP-labeled neurons	12421
@VP	visualize HRP-labeled neurons	12424
@VP	were tested for locomotor function by two observers	12695
@VP	tested for locomotor function by two observers	12700
@VP	blinded to the treatment groups	12747
@VP	was performed weekly , beginning 1 week post transplantation	12792
@VP	performed weekly , beginning 1 week post transplantation	12796
@VP	beginning 1 week post transplantation	12814
@VP	continued up to 6 weeks post transplantation	12856
@VP	were anesthetized with 3 % sodium pentobarbiturate	13040
@VP	fixed followed by an injection of atropine sulfate -LRB- 0.8 mg/kg -RRB-	13110
@VP	reducing tracheal secretions	13177
@VP	placed on the surface of the sensorimotor cortex	13488
@VP	was analyzed in terms of latency and amplitude	13612
@VP	analyzed in terms of latency and amplitude	13616
@VP	performing evoked potentials on all subjects	13666
@VP	evoked potentials on all subjects	13677
@VP	were removed for histological processing	13729
@VP	removed for histological processing	13734
@VP	were collected and expressed as means ± standard error	13879
@VP	collected and expressed as means ± standard error	13884
@VP	± standard error	13916
@VP	was used to analyze the data between groups	13961
@VP	used to analyze the data between groups	13965
@VP	to analyze the data between groups	13970
@VP	analyze the data between groups	13973
@VP	followed by Dunnett 's post-hoc multiple comparison tests	14020
@VP	was used to evaluate CSEP	14077
@VP	used to evaluate CSEP	14081
@VP	to evaluate CSEP	14086
@VP	evaluate CSEP	14089
@VP	was considered statistically significant	14134
@VP	considered statistically significant	14138
@VP	3	14177
@VP	contused cord over six weeks on the longitudinal frozen sections	14253
@VP	formed from confluence of tissue spaces and cysts -LRB- D -- D1 -RRB-	14564
@VP	arrayed along the wall of the cavity	14640
@VP	floated in the cavity -LRB- E -- E1 = 5 weeks ; and F -- F1 = 6 weeks -RRB-	14681
@VP	are present together with OECs	14764
@VP	are enlargements of the frames in A -- F.	14802
@VP	bar = 100 μm in A -- F , 220 μm in A1 -- F1	14847
@VP	destroyed due to the formation of the large cavity at 4 weeks -LRB- A4 -RRB-	15282
@VP	could be seen in the ventral and ventrolateral areas at 6 weeks -LRB- A6 -RRB-	15458
@VP	be seen in the ventral and ventrolateral areas at 6 weeks -LRB- A6 -RRB-	15464
@VP	seen in the ventral and ventrolateral areas at 6 weeks -LRB- A6 -RRB-	15467
@VP	was deteriorated from 2 to 6 weeks -LRB- B2 -- B6 -RRB-	15586
@VP	deteriorated from 2 to 6 weeks -LRB- B2 -- B6 -RRB-	15590
@VP	were much healthier with less damage and denser parenchyma	15641
@VP	bar = 200 μm	15707
@VP	= 200 μm	15710
@VP	contused spinal cord receiving DMEM and OEC injections	15820
@VP	receiving DMEM and OEC injections	15841
@VP	increased	15943
@VP	decreased in both groups over six weeks post transplantation	15973
@VP	could be encountered at each time point	16082
@VP	be encountered at each time point	16088
@VP	encountered at each time point	16091
@VP	scattered in the injured area -LRB- A1 and B1 -RRB- , then	16324
@VP	was greater in the OEC group than in the control group at each time point	16490
@VP	bar = 100 μm	16571
@VP	= 100 μm	16574
@VP	bar = 150 μm	16922
@VP	= 150 μm	16925
@VP	was higher than that of DMEM rats at each time point	17174
@VP	+ = pb0 .01 and + = pb0 .05	17229
@VP	injected animals at the sixth week after transplantation	17306
@VP	was decreased	17378
@VP	decreased	17382
@VP	was prolonged compared to the normal -LRB- A -RRB-	17408
@VP	prolonged compared to the normal -LRB- A -RRB-	17412
@VP	was significant	17547
@VP	compared between the DMED and the OEC groups	17612
@VP	was formed At 1 week after the contusion	17855
@VP	formed At 1 week after the contusion	17859
@VP	migrated into the surrounding tissue for a short distance	18225
@VP	were formed from confluence of tissue spaces and cysts	18333
@VP	formed from confluence of tissue spaces and cysts	18338
@VP	pushed towards the wall by the liquid in the cavities -LRB- Fig. 1D , D1 -RRB-	18435
@VP	arranging along the wall of the cavity	18614
@VP	floated in the cavity -LRB- Fig. 1E -- F , E1 -- F1 -RRB-	18657
@VP	could be found with OECs -LRB- Fig. 1F , F1 -RRB-	18729
@VP	be found with OECs -LRB- Fig. 1F , F1 -RRB-	18735
@VP	found with OECs -LRB- Fig. 1F , F1 -RRB-	18738
@VP	increased the intact tissue of the contused spinal cord	18779
@VP	contused spinal cord	18814
@VP	reduce cavity formation in the spinal cord At 1 week after transplantation	18848
@VP	were found	19085
@VP	found	19090
@VP	was enlarged gradually with fusion of the cysts and formation of micro cavities	19125
@VP	resulting in decrease of intact parenchyma of the cord	19304
@VP	could be seen in ventral and ventrolateral areas at 6 weeks post transplantation	19391
@VP	be seen in ventral and ventrolateral areas at 6 weeks post transplantation	19397
@VP	seen in ventral and ventrolateral areas at 6 weeks post transplantation	19400
@VP	developed in both groups	19513
@VP	were more healthy	19580
@VP	used to assess the areas of injured and intact tissue and the cavity size	19782
@VP	to assess the areas of injured and intact tissue and the cavity size	19787
@VP	assess the areas of injured and intact tissue and the cavity size	19790
@VP	to form larger cavities from 0.05 mm2 to 0.16 mm2 during the following two weeks	19998
@VP	form larger cavities from 0.05 mm2 to 0.16 mm2 during the following two weeks	20001
@VP	receiving DMEM	20288
@VP	increased from 1.35 mm2 at 1 week to 2.02 mm2 at 6 weeks	20303
@VP	decreased from 1.47 mm2 to 0.8 mm2 over 6 weeks -LRB- Fig. 3A , B -RRB-	20390
@VP	receiving OECs increased from 0.41 mm2 to 0.82 mm2	20499
@VP	increased from 0.41 mm2 to 0.82 mm2	20514
@VP	was achieved only at 1 week after transplantation -LRB- pb0 .01 -RRB-	20723
@VP	achieved only at 1 week after transplantation -LRB- pb0 .01 -RRB-	20727
@VP	increased the number of myelinated nerve fibers in the lesion site	20793
@VP	protected neurons in the rostral segment of the spinal cord	20864
@VP	receiving OECs	20939
@VP	increased during the following weeks -LRB- Fig. 4B1 -- B6 -RRB-	21074
@VP	could be found in the control animals	21144
@VP	be found in the control animals	21150
@VP	found in the control animals	21153
@VP	were detectable at 6 weeks after transplantation -LRB- Fig. 5 -RRB-	21697
@VP	was counted on an area of 1.64 mm2 from different sections	21795
@VP	counted on an area of 1.64 mm2 from different sections	21799
@VP	was significantly more than 65 ± 13 in the DMEM group -LRB- pb0 .01 -RRB-	21936
@VP	improved locomotor performance of the transplanted rats	22008
@VP	averaged 7.2 ± 1.27 , compared to 3.25 ± 1.13 for DMEM injected rats	22245
@VP	injected rats	22295
@VP	could be recorded in both OECs and DMEM	22726
@VP	be recorded in both OECs and DMEM	22732
@VP	recorded in both OECs and DMEM	22735
@VP	injected animals	22766
@VP	was decreased	22806
@VP	decreased	22810
@VP	was prolonged compared to the normal -LRB- Fig. 7A -RRB-	22836
@VP	prolonged compared to the normal -LRB- Fig. 7A -RRB-	22840
@VP	was performed	23097
@VP	performed	23101
@VP	was found -LRB- Fig. 7B -RRB-	23142
@VP	found -LRB- Fig. 7B -RRB-	23146
@VP	was significant -LRB- Fig. 7C -RRB-	23361
@VP	4	23389
@VP	were transplanted into contused spinal cord of rats	23438
@VP	transplanted into contused spinal cord of rats	23443
@VP	protected injured spinal cord and kept relations with the cavity	23545
@VP	protected injured spinal cord	23545
@VP	kept relations with the cavity	23579
@VP	survived in the contused cord	23710
@VP	contused cord	23726
@VP	is unfavorable for OECs	23872
@VP	to survive and migrate	23896
@VP	survive and migrate	23899
@VP	was demonstrated by differences in the survival rate -LSB- 28 -RSB-	23978
@VP	demonstrated by differences in the survival rate -LSB- 28 -RSB-	23982
@VP	was delayed until 7 days after contusion	24084
@VP	delayed until 7 days after contusion	24088
@VP	carried out at the time of injury -LSB- 29 -RSB-	24134
@VP	increased when co-cultured with acutely injured spinal cord explants	24231
@VP	co-cultured with acutely injured spinal cord explants	24246
@VP	transplanted into the injured spinal cord	24355
@VP	cease dividing after 24 h -LSB- 31 -RSB-	24397
@VP	dividing after 24 h -LSB- 31 -RSB-	24403
@VP	can survive in the host spinal cord for 2 to 8 months -LSB- 32	24483
@VP	survive in the host spinal cord for 2 to 8 months -LSB- 32	24487
@VP	are left from the number transplanted -LSB- 35 -RSB-	24588
@VP	left from the number transplanted -LSB- 35 -RSB-	24592
@VP	injected into lesion site	24794
@VP	remained in or nearby the injection / lesion site	24832
@VP	could enter the lesion	24939
@VP	enter the lesion	24945
@VP	can be induced by injury signals and are able to support axonal re-growth	24979
@VP	can be induced by injury signals	24979
@VP	be induced by injury signals	24983
@VP	induced by injury signals	24986
@VP	are able to support axonal re-growth	25016
@VP	to support axonal re-growth	25025
@VP	support axonal re-growth	25028
@VP	sprouting into the lesion -LSB- 37 -RSB-	25060
@VP	has been confirmed previously -LSB- 29,38	25226
@VP	been confirmed previously -LSB- 29,38	25230
@VP	confirmed previously -LSB- 29,38	25235
@VP	labeled by CB-HRP in rostral segment to the lesion sites	25436
@VP	were increased in number after OEC transplantation -LRB- Fig. 3C -RRB-	25493
@VP	increased in number after OEC transplantation -LRB- Fig. 3C -RRB-	25498
@VP	remains	25604
@VP	injured rats -LSB- 39 -RSB-	25722
@VP	Taken these facts with more neurons together	25741
@VP	counteract secondary tissue degeneration after spinal cord injury	25817
@VP	is unclear	25933
@VP	expressed by OECs	26038
@VP	may be involved -LSB- 14,15	26056
@VP	be involved -LSB- 14,15	26060
@VP	involved -LSB- 14,15	26063
@VP	has been shown to reduce tissue necrosis after spinal cord injury -LSB- 40 -RSB-	26086
@VP	been shown to reduce tissue necrosis after spinal cord injury -LSB- 40 -RSB-	26090
@VP	shown to reduce tissue necrosis after spinal cord injury -LSB- 40 -RSB-	26095
@VP	to reduce tissue necrosis after spinal cord injury -LSB- 40 -RSB-	26101
@VP	reduce tissue necrosis after spinal cord injury -LSB- 40 -RSB-	26104
@VP	Injured ascending sensory axons	26158
@VP	ascending sensory axons	26166
@VP	are responsive to NGF , BDNF , and NT-3 -LSB- 16 -- 18,41,42 -RSB-	26228
@VP	prevents atrophy of rat rubrospinal neurons after axotomy	26288
@VP	promotes rubrospinal regeneration -LSB- 19 -RSB-	26350
@VP	is an important process removing cellular debris after injury	26560
@VP	removing cellular debris after injury	26584
@VP	may be beneficial in reducing secondary damage to the cord	26626
@VP	be beneficial in reducing secondary damage to the cord	26630
@VP	reducing secondary damage to the cord	26647
@VP	-LSB- 43 -RSB-	26685
@VP	is related to the re-myelination of the fibers after SCI	26898
@VP	related to the re-myelination of the fibers after SCI	26901
@VP	can re-myelinate the nerve fibers after SCI -LSB- 44 , also review in Ref	27016
@VP	re-myelinate the nerve fibers after SCI -LSB- 44 , also review in Ref	27020
@VP	is important because remaining deficits after injury	27096
@VP	are partly caused by demyelination of spared axons -LSB- 46 -RSB-	27149
@VP	caused by demyelination of spared axons -LSB- 46 -RSB-	27160
@VP	needed	27451
@VP	evoked by the transplantation and the OECs	27588
@VP	does is to improve the function of the injured cord at a later stage	27658
@VP	is to improve the function of the injured cord at a later stage	27663
@VP	to improve the function of the injured cord at a later stage	27666
@VP	improve the function of the injured cord at a later stage	27669
@VP	may be enhanced by the neurotrophic factors	27753
@VP	be enhanced by the neurotrophic factors	27757
@VP	enhanced by the neurotrophic factors	27760
@VP	are automobile collisions	27833
@VP	followed by violence	27860
@VP	falls	27882
@VP	caudal to the level of injury	28019
@VP	is completely lost -LSB- reviewed in reference 48 -RSB-	28049
@VP	lost -LSB- reviewed in reference 48 -RSB-	28063
@VP	followed by cavity formation	28222
@VP	were observed whereas the anatomical structure of the cord was improved	28430
@VP	observed whereas the anatomical structure of the cord was improved	28435
@VP	was improved	28489
@VP	improved	28493
@VP	sizewas not reduced by the OEC transplantation	28518
@VP	reduced by the OEC transplantation	28530
@VP	reported by Plant	28617
@VP	transplanted bulb - and mucosa-derived OECs into the contused T9	28700
@VP	caused by the contusion and the crush	28931
@VP	is different	28969
@VP	was imposed in this study	29035
@VP	imposed in this study	29039
@VP	resulted in 9.9 % and 23 %	29133
@VP	spared tissue respectively -LSB- 26 -RSB-	29158
@VP	used previously	29254
@VP	may contribute to the difference	29302
@VP	contribute to the difference	29306
@VP	should be ascertained in the future study	29393
@VP	be ascertained in the future study	29400
@VP	ascertained in the future study	29403
@VP	was not inhibited by the OEC transplantation	29494
@VP	inhibited by the OEC transplantation	29502
@VP	receiving OECs	29552
@VP	was confirmed previously by Ruitenberg , et al. , 2003 -LSB- 46 -RSB-	29731
@VP	confirmed previously by Ruitenberg , et al. , 2003 -LSB- 46 -RSB-	29735
@VP	was significantly improved	29850
@VP	judged from their amplitude and latency	29877
@VP	contused spinal cord	29996
@VP	was not recovered to normal level	30017
@VP	recovered to normal level	30025
@VP	improved spinal cord function	30068
@VP	may result from the protective potential of OECs on the host tissue	30098
@VP	result from the protective potential of OECs on the host tissue	30102
@VP	was much healthier in animals receiving OECs transplantation	30311
@VP	receiving OECs transplantation	30341
@VP	influences impaired hind limb performance	30530
